Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
32 "Autoimmune"
Filter
Filter
Article type
Keywords
Publication year
Authors
Special Article
Miscellaneous
COVID-19 Vaccination for Endocrine Patients: A Position Statement from the Korean Endocrine Society
Cheol Ryong Ku, Kyong Yeun Jung, Chang Ho Ahn, Jun Sung Moon, Ju Hee Lee, Eun Heui Kim, Hyemi Kwon, Hee Kyung Kim, Sunghwan Suh, Sangmo Hong, Jeonghoon Ha, Eun Roh, Jin Hwa Kim, Mi-kyung Kim, the Committee of Clinical Practice Guideline of the Korean Endocrine Society
Endocrinol Metab. 2021;36(4):757-765.   Published online August 17, 2021
DOI: https://doi.org/10.3803/EnM.2021.404
  • 10,540 View
  • 420 Download
  • 19 Web of Science
  • 21 Crossref
AbstractAbstract PDFPubReader   ePub   
Since the first outbreak of coronavirus disease 2019 (COVID-19), ongoing efforts have been made to discover an efficacious vaccine against COVID-19 to combat the pandemic. In most countries, both mRNA and DNA vaccines have been administered, and their side effects have also been reported. The clinical course of COVID-19 and the effects of vaccination against COVID-19 are both influenced by patients’ health status and involve a systemic physiological response. In view of the systemic function of endocrine hormones, endocrine disorders themselves and the therapeutics used to treat them can influence the outcomes of vaccination for COVID-19. However, there are very limited data to support the development of clinical guidelines for patients with specific medical backgrounds based on large clinical trials. In the current severe circumstances of the COVID-19 pandemic, position statements made by clinical specialists are essential to provide appropriate recommendations based on both medical evidence and clinical experiences. As endocrinologists, we would like to present the medical background of COVID-19 vaccination, as well as precautions to prevent the side effects of COVID-19 vaccination in patients with specific endocrine disorders, including adrenal insufficiency, diabetes mellitus, osteoporosis, autoimmune thyroid disease, hypogonadism, and pituitary disorders.

Citations

Citations to this article as recorded by  
  • COVID-19 mRNA vaccine may trigger subacute thyroiditis
    Mehmet Sözen, Ömercan Topaloğlu, Berrin Çetinarslan, Alev Selek, Zeynep Cantürk, Emre Gezer, Damla Köksalan, Taner Bayraktaroğlu
    Human Vaccines & Immunotherapeutics.2024; 17(12): 5120.     CrossRef
  • The role of co-morbidities in the development of an AEFI after COVID-19 vaccination in a large prospective cohort with patient-reported outcomes in the Netherlands
    C. Ouaddouh, J.W. Duijster, T. Lieber, F.P.A.M. van Hunsel
    Expert Opinion on Drug Safety.2024; 23(3): 323.     CrossRef
  • Thyroid dysfunction in COVID-19
    David Tak Wai Lui, Chi Ho Lee, Yu Cho Woo, Ivan Fan Ngai Hung, Karen Siu Ling Lam
    Nature Reviews Endocrinology.2024; 20(6): 336.     CrossRef
  • Adult-Onset Type 1 Diabetes Development Following COVID-19 mRNA Vaccination
    Hyeyeon Moon, Sunghwan Suh, Mi Kyoung Park
    Journal of Korean Medical Science.2023;[Epub]     CrossRef
  • Prior immunization status of COVID-19 patients and disease severity: A multicenter retrospective cohort study assessing the different types of immunity
    Javaria Aslam, Faisal Shahzad Khan, Muhammad Talha Haris, Hewad Hewadmal, Maryam Khalid, Mohammad Y. Alshahrani, Qurrat-ul-ain Aslam, Irrum Aneela, Urooj Zafar
    Vaccine.2023; 41(2): 598.     CrossRef
  • Mortality and Severity of Coronavirus Disease 2019 in Patients with Long-Term Glucocorticoid Therapy: A Korean Nationwide Cohort Study
    Eu Jeong Ku, Keeho Song, Kyoung Min Kim, Gi Hyeon Seo, Soon Jib Yoo
    Endocrinology and Metabolism.2023; 38(2): 253.     CrossRef
  • Pituitary Diseases and COVID-19 Outcomes in South Korea: A Nationwide Cohort Study
    Jeonghoon Ha, Kyoung Min Kim, Dong-Jun Lim, Keeho Song, Gi Hyeon Seo
    Journal of Clinical Medicine.2023; 12(14): 4799.     CrossRef
  • Inactivated SARS-CoV-2 vaccination does not disturb the clinical course of Graves’ disease: An observational cohort study
    Shichen Xu, Huixin Yu, Xian Cheng, Jing Wu, Jiandong Bao, Li Zhang
    Vaccine.2023; 41(38): 5648.     CrossRef
  • Adrenal Crisis Associated With COVID-19 Vaccination in Patients With Adrenal Insufficiency
    Yukako Kurematsu, Takako Mohri, Sadanori Okada, Yutaka Takahashi
    JCEM Case Reports.2023;[Epub]     CrossRef
  • Adverse Events Associated with COVID-19 Vaccination in Adolescents with Endocrinological Disorders: A Cross-Sectional Study
    İbrahim Mert Erbaş, İrem Ceren Erbaş, Gözde Akın Kağızmanlı, Kübra Yüksek Acinikli, Özge Besci, Korcan Demir, Ece Böber, Nurşen Belet, Ayhan Abacı
    Journal of Clinical Research in Pediatric Endocrinology.2023; 15(3): 248.     CrossRef
  • Neue Aspekte der Glukokortikoidsubstitution bei Nebennierenrindeninsuffizienz
    Tina Kienitz, Gesine Meyer
    Der Internist.2022; 63(1): 12.     CrossRef
  • Endocrine Follow-up During Post-Acute COVID-19: Practical Recommendations Based on Available Clinical Evidence
    Rimesh Pal, Ameya Joshi, Sanjay K. Bhadada, Mainak Banerjee, Suresh Vaikkakara, Satinath Mukhopadhyay
    Endocrine Practice.2022; 28(4): 425.     CrossRef
  • Safety of Inactivated and mRNA COVID-19 Vaccination Among Patients Treated for Hypothyroidism: A Population-Based Cohort Study
    Xi Xiong, Carlos King Ho Wong, Ivan Chi Ho Au, Francisco Tsz Tsun Lai, Xue Li, Eric Yuk Fai Wan, Celine Sze Ling Chui, Esther Wai Yin Chan, Franco Wing Tak Cheng, Kristy Tsz Kwan Lau, Chi Ho Lee, Yu Cho Woo, David Tak Wai Lui, Ian Chi Kei Wong
    Thyroid.2022; 32(5): 505.     CrossRef
  • The New Entity of Subacute Thyroiditis amid the COVID-19 Pandemic: From Infection to Vaccine
    Mihaela Popescu, Adina Ghemigian, Corina Maria Vasile, Andrei Costache, Mara Carsote, Alice Elena Ghenea
    Diagnostics.2022; 12(4): 960.     CrossRef
  • Adrenal Crisis Secondary to COVID-19 Vaccination in a Patient With Hypopituitarism
    Nikolina Markovic, Anila Faizan, Chirag Boradia, Sridhar Nambi
    AACE Clinical Case Reports.2022; 8(4): 171.     CrossRef
  • The Effect of Inactivated SARS-CoV-2 Vaccines on TRAB in Graves’ Disease
    LingHong Huang, ZhengRong Jiang, JingXiong Zhou, YuPing Chen, HuiBin Huang
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Osteoporosis in Patients With Respiratory Diseases
    Yue Ma, Shui Qiu, Renyi Zhou
    Frontiers in Physiology.2022;[Epub]     CrossRef
  • Pilot Findings on SARS-CoV-2 Vaccine-Induced Pituitary Diseases: A Mini Review from Diagnosis to Pathophysiology
    Ach Taieb, El Euch Mounira
    Vaccines.2022; 10(12): 2004.     CrossRef
  • Forty Years Together, New Leap Forward! The 40th Anniversary of the Korean Endocrine Society
    Jong Chul Won, Ki-Hyun Baek
    Endocrinology and Metabolism.2022; 37(6): 851.     CrossRef
  • No need of glucocorticoid dose adjustment in patients with adrenal insufficiency before COVID-19 vaccine
    Tania Pilli, Cristina Dalmiglio, Gilda Dalmazio, Alfonso Sagnella, Raffaella Forleo, Lucia Brilli, Fabio Maino, Cristina Ciuoli, Maria Grazia Castagna
    European Journal of Endocrinology.2022; 187(1): K7.     CrossRef
  • Diabetes and COVID-19 Vaccination
    Hae Dong Choi, Jun Sung Moon
    The Journal of Korean Diabetes.2021; 22(4): 221.     CrossRef
Close layer
Original Article
Spontaneous Recovery from Hypothyroidism in Autommune Thyroiditis.
Bo Youn Cho, Jae Hoon Chung, Kwang Won Kim, Kyu Jeung Ahn, Yong Ki Min, Myung Shik Lee, Moon Kyu Lee
J Korean Endocr Soc. 1996;11(1):30-40.   Published online November 7, 2019
  • 2,220 View
  • 35 Download
AbstractAbstract PDF
Background
A lifelong thyroxine therapy is indicated in all patients who have hypothyroidism as a result of autoimmune thyroiditis. However, it has been reported that some hypothyroid patients with autoimmune thyroiditis have spontaneous remission with restriction of iodine intake instead of thyroxine therapy. The purpose of study was to investigate how many hypothyroid patients with autoimmune thyroiditis can recover from hypothyroidism with restriction of iodine intake instead of thyroxine therapy and which factors predict recovery from hypothyroidism. Methods: We studied 64 patients with autoimmune thyroiditis(goitrous autoimmune thyroiditis 56, atrophic autoimmune thyroiditis 8). Thyroxine therapy was discontinued in patients with goitrous autoimmune thyroiditis on the way(group 1, n=32) or from the beginning(group 2, n=24) and atrophic autoimmune thyroiditis on the way(group 3, n-8). All patients were asked to avoid iodine-rich foods and thyroid function was monitored every one to two months for up to 35 months. Serum T3, T4, TSH concentrations, antithyroglobulin and antimicrosomal antibodies were measured by radioimmunoassay(RIA). TSH binding inhibitor immunoglobulin(TBII) was measured in serum using radioreceptor assay. Two hundred micrograms of thyrotropin releasing hormone (TRH) were given as intravenous bolus and TSH levels were measured in blood samples taken at 0, 30, and 60 minutes. All values were expressed as mean+-SEM. Statistical analysis was done with paired or non-paired t-test, ANOVA, and the Chi-square test. Statistical significance was defined as p-value below 0.05. Results: Thirteen(40.6%) of 32 patients in group 1 remained euthyroid after 12-35 months of discontinuation of thyroxine therapy. The other 19(59.4%) patients in group 1 had recurrences of hypothyroidism within 3 months after discontinuation of thyroxine therapy. In 11(45.8%) out of 24 patients in group 2, serum TSH concentrations declined below 5 mU/L within 3 months without thyroxine therapy. The other 13(54.2%) patients in group 2 remained hypothyroid till 2-16 months and the thyroxine was given. In contrast, all 8 patients in group 3 had recurrences of hypothy- roidism within 3 months after stopping thyroxine therapy. When we compared the recovered patients of goitrous autoimmune thyroiditis with the non-recovered patients of goitrous autoimmune thyroiditis, regardless of thyroxine therapy from the beginning, age at onset of disease of the 24 recovered patients was significantly younger than the 32 non-recovered patients(30.1+2.0 years vs. 40.2+ 2.4 years; p=0.004). Concl#usion: These findings suggest that 42.9% of hypothyroid patients with goitrous autoim- mune thyroiditis remain or become spontaneously euthyroid with restriction of iodine intake instead of thyroxine therapy. Young age may be a predicting factor of recovery from hypothyroidism in goitrous autoimmune thyroiditis.
Close layer
Case Reports
A Korean Pedigree of Paget Bone Disease: Including a Case of Panostotic Paget Bone Disease complicated with Giant Cell Reparative Granuloma.
Eui Tae Jeong, Jae Hong Park, Do Hyeong Kim, Byoung Oh Jeong, Kyung Soo Ko, Byoung Doo Rhee
J Korean Endocr Soc. 1995;10(4):456-466.   Published online November 7, 2019
  • 970 View
  • 20 Download
AbstractAbstract PDF
The polyglandular autoimmune syndrome designates the dysfunction of endocrine and nonendocrine system involving two or more organs on the basis of an autoimmune mechanism. The autoimmune nature of these diseases has been based on the presence of lymphocytic infiltration in the affected gland, organ specific autoantibodies in the serum, cellular immune defects and an association with the HLA DR/DQ genes or immune response genes. This syndrome is usually classified into three classes and their etiology or pathogenesis is still not completely understood. A 28-year-old woman developed vitiligo and insulin dependent diabetes mellitus during the treatment of Graves' disease with antithyroid drug. She had a tendency of spontaneous ketonemia and serum c-peptide levels were low(0.21, 0.16ng/mL: fasting and glucagon stimulated). Thyrotrophin binding inhibitor immunoglobulin and pancreas iIslet cell cytoplasmic antibody were positive. We report here a case of polyglandular autoimmune syndrome, type III manifesting Graves' disease, vitiligo, and insulin dependent diabetes mellitus.
Close layer
A Case of Polyglandular Autoimmune Syndrome.
In Pyo Jun, Suck Hwan Lim, Won Hyep Bae, Seung Jun Kim, Youn Ho Lee, Sun Ho Kim, Jung Kyu Lim, Jin Duk Hur
J Korean Endocr Soc. 1994;10(2):142-147.   Published online November 6, 2019
  • 1,172 View
  • 20 Download
AbstractAbstract PDF
Polyglandular autoimmune(PGA) syndrome designates the dysfunction of endocrine and nonendocrine system involving two or more glands on the basis of autoimmunity. There are three types of PGA syndrome and their pathogenesis is still not completely understood. A 27-year-old woman developed polyglandular autoimmune syndrome manifesting insulin-dependent diabetes mellitus, myasthenia gravis and Graves' disease associated papillary thyroid carcinoma. The thyroid antimicrosomal antibody and antiacetylcholine receptor antibody were positive. Her HLA serotype was A2, A11, A62, B60, CW3, CW4, DR4, DR9.We report here a case of polyglandular autoimmune syndrome, type III manifesting insulin-dependent diabetes mellitus, myasthenia gravis and Graves' disease associated with papillary thyroid carcinoma.
Close layer
Review Article
Diabetes
Latent Autoimmune Diabetes in Adults: Current Status and New Horizons
Paolo Pozzilli, Silvia Pieralice
Endocrinol Metab. 2018;33(2):147-159.   Published online June 21, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.2.147
  • 14,308 View
  • 385 Download
  • 52 Web of Science
  • 46 Crossref
AbstractAbstract PDFPubReader   ePub   

Autoimmune diabetes is a heterogeneous disease which can arise at any age. Subjects with adult-onset autoimmune diabetes who do not necessitate insulin-therapy for at least 6 months after diagnosis are demarcated as having latent autoimmune diabetes in adults (LADA). This condition is more heterogeneous than young-onset autoimmune diabetes and shares clinical and metabolic characteristics with both type 2 and type 1 diabetes. Patients with LADA are considered by having highly variable β-cell destruction, different degrees of insulin resistance and heterogeneous titre and pattern of islet autoantibody, suggesting different pathophysiological pathways partially explaining the heterogeneous phenotypes of LADA. To date the heterogeneity of LADA does not allow to establish a priori treatment algorithm and no specific guidelines for LADA therapy are available. These subjects are mostly treated as affected by type 2 diabetes, a factor that might lead to the progression to insulin-dependency quickly. A personalised medicine approach is necessary to attain optimal metabolic control and preserve β-cell function to decrease the risk of long-term diabetes complications. Recent data concerning the use of oral antidiabetic agents as dipeptidyl peptidase 4 inhibitors and glucagon-like peptide 1 receptor agonists indicate up-and-coming results in term of protect C-peptide levels and improving glycaemic control. This review summarises current knowledge on LADA, emphasising controversies regarding its pathophysiology and clinical features. Moreover, we discuss data available about novel therapeutic approaches that can be considered for prevention of β-cell loss in LADA.

Citations

Citations to this article as recorded by  
  • Utility of Fasting C-Peptide for the Diagnostic Differentiation of Patients with Type 1, Type 2 Diabetes, MODY, and LADA
    Ricardo Alemán-Contreras, Rita A. Gómez-Díaz, Maura E. Noyola-García, Rafael Mondragón-González, Niels Wacher, Aldo Ferreira-Hermosillo
    Life.2024; 14(5): 550.     CrossRef
  • Drug candidates and potential targets of Curculigo spp. compounds for treating diabetes mellitus based on network pharmacology, molecular docking and molecular dynamics simulation
    Abdul Halim Umar, Diah Ratnadewi, Mohamad Rafi, Yohana Caecilia Sulistyaningsih, Hamim Hamim, Wisnu Ananta Kusuma
    Journal of Biomolecular Structure and Dynamics.2023; 41(17): 8544.     CrossRef
  • Development and validation of a clinical score for identifying patients with high risk of latent autoimmune adult diabetes (LADA): The LADA primary care-protocol study
    Pilar Vich-Pérez, Juan Carlos Abánades-Herranz, Gustavo Mora-Navarro, Ángela María Carrasco-Sayalero, Miguel Ángel Salinero-Fort, Ignacio Sevilla-Machuca, Mar Sanz-Pascual, Cristina Álvarez Hernández-Cañizares, Carmen de Burgos-Lunar, Vijayaprakash Suppia
    PLOS ONE.2023; 18(2): e0281657.     CrossRef
  • Diagnostic Dilemmas and Current Treatment Approaches in Latent Onset Autoimmune Diabetes in Adults: A Concise Review
    Lakshmi Chandran, Ankul Singh S., Chitra Vellapandian
    Current Diabetes Reviews.2023;[Epub]     CrossRef
  • Characteristics of adult-onset auto-immune type 1 diabetes
    Faten Hadj Kacem, Ameni Jerbi, Bibi Twaheerah Allymamod, Wafa Bel Abed, Mouna Mnif, Nadia Charfi, Mouna Elleuch, Nabila Rekik, Hatem Masmoudi, Mohamed Abid
    The American Journal of the Medical Sciences.2023; 366(1): 49.     CrossRef
  • The role of cholecalciferol deficiency in the development of latent autoimmune diabetes in adults
    I.O. Tsaryk, N.V. Pashkovska
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2023; 19(4): 259.     CrossRef
  • Newly diagnosed type 1 diabetes mellitus in a human immunodeficiency virus-infected patient with antiretroviral therapy-induced immune reconstitution inflammatory syndrome: a case report
    Min-ChunYeh, Han-Chuan Chuang, Shuen-Fu Weng, Chung-Huei Hsu, Chen-Ling Huang, Yu-Pei Lin, Yan-Yu Lin, Yu-Shan Hsieh
    BMC Infectious Diseases.2023;[Epub]     CrossRef
  • A Review on Latent Autoimmune Diabetes in Adults
    Vijay Ravikumar, Ariba Ahmed, Ashish Anjankar
    Cureus.2023;[Epub]     CrossRef
  • Exploring Immune Therapies in a Twin Case of Latent Autoimmune Diabetes in Adults and Generalized Granuloma Annulare
    Brian W. Connor, Sarah E.B. Smith, Andrea Kalus
    Clinical Diabetes.2023; 41(4): 583.     CrossRef
  • Innate immunity in latent autoimmune diabetes in adults
    Juan Huang, James Alexander Pearson, F. Susan Wong, Li Wen, Zhiguang Zhou
    Diabetes/Metabolism Research and Reviews.2022;[Epub]     CrossRef
  • Endocrine Manifestations and New Developments in Mitochondrial Disease
    Yi Shiau Ng, Albert Zishen Lim, Grigorios Panagiotou, Doug M Turnbull, Mark Walker
    Endocrine Reviews.2022; 43(3): 583.     CrossRef
  • Two Fifth-Generation Fighter Pilots Discovered with Latent Autoimmune Diabetes
    Joe X. Zhang, Jacob Berry, Nathan M. Kim, Justin J. Gray, Savannah Fotheringham, Tom J. Sauerwein
    Aerospace Medicine and Human Performance.2022; 93(2): 106.     CrossRef
  • A Case of Late Diagnosis of Latent Autoimmune Diabetes in Adults
    Joana R Costa, Ana Mestre, Mariana S Miranda, Frederica H Ferreira, Yahia Abuowda
    Cureus.2022;[Epub]     CrossRef
  • Class I MHC Polymorphisms Associated with Type 2 Diabetes in the Mexican Population
    Paola Mendoza-Ramírez, Mildred Alejandra López-Olaiz, Adriana Lizeth Morales-Fernández, María Isabel Flores-Echiveste, Antonio de Jesus Casillas-Navarro, Marco Andrés Pérez-Rodríguez, Felipe de Jesús Orozco-Luna, Celso Cortés-Romero, Laura Yareni Zuñiga,
    Genes.2022; 13(5): 772.     CrossRef
  • Efficacy and safety of sitagliptin and insulin for latent autoimmune diabetes in adults: A systematic review and meta‐analysis
    Tong Lin, Yinhe Cai, Liting Tang, Youwei Lian, Min Liu, Chaonan Liu
    Journal of Diabetes Investigation.2022; 13(9): 1506.     CrossRef
  • Partial Remission of Diabetes in a Young Adult While Testing Positive for Several Islet Cell Autoantibodies: A Case Report, Literature Review, and Patient Perspective
    Samson O Oyibo
    Cureus.2022;[Epub]     CrossRef
  • Latent Autoimmune Diabetes in Adults and Metabolic Syndrome—A Mini Review
    Niansi Pan, Shimei Yang, Xiaohong Niu
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Prevalence and factors associated with latent autoimmune diabetes in adults (LADA): a cross-sectional study
    Anselmo M. Manisha, Aminiel R. Shangali, Sayoki G. Mfinanga, Erasto V. Mbugi
    BMC Endocrine Disorders.2022;[Epub]     CrossRef
  • Diabetic ketoacidosis as first presentation of latent autoimmune diabetes in adults in a patient with hashitoxicosis as first presentation of Hashimoto’s thyroiditis: a case report
    Maria Xenou, Ioannis Zoupas, Dimitrios Lygnos, Evangelos Fousteris
    Journal of Medical Case Reports.2022;[Epub]     CrossRef
  • Latent Autoimmune Diabetes in Adults (LADA): From Immunopathogenesis to Immunotherapy
    Jingyi Hu, Rong Zhang, Hailan Zou, Lingxiang Xie, Zhiguang Zhou, Yang Xiao
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Adult-onset autoimmune diabetes
    Raffaella Buzzetti, Ernesto Maddaloni, Jason Gaglia, R. David Leslie, F. Susan Wong, Bernhard O. Boehm
    Nature Reviews Disease Primers.2022;[Epub]     CrossRef
  • Diagnostic camouflage: A case report on Latent autoimmune diabetics of adulthood
    Sandhya kiran Neupane, Prakash Paudel Jaishi, Divyaa Koirala, Arjun Kandel, Prabhat Kiran Neupane
    Annals of Medicine and Surgery.2022; 82: 104699.     CrossRef
  • A Mechanistic Insight on Phytoconstituents Delivering Hypoglycemic Activity: A Comprehensive Overview
    Shraddha Singh Raghav, Bhavna Kumar, Neeraj Kumar Sethiya, Ankur Kaul
    Future Pharmacology.2022; 2(4): 511.     CrossRef
  • Diagnostic dilemmas in young onset diabetes mellitus
    Avijit Saha, Parna Roy
    Annals of Medical Science and Research.2022; 1(3): 111.     CrossRef
  • Prevalence of diabetes-associated autoantibodies among patients presenting with type 2 diabetes and related metabolic differences
    Fatemeh Moosaie, Neda Meftah, Niloofar Deravi, Kosar Abouhamzeh, Fatemeh Dehghani Firouzabadi, Pegah Khaloo, Mohammad Ali Mansournia, Seyede Marzie Fatemi Abhari, Manouchehr Nakhjavani, Alireza Esteghamati
    Primary Care Diabetes.2021; 15(1): 169.     CrossRef
  • The association of human leukocyte antigen class II (HLA II) haplotypes with the risk of Latent autoimmune diabetes of adults (LADA): Evidence based on available data
    Wenjun Chen, Xinlin Chen, Minting Zhang, Zunnan Huang
    Gene.2021; 767: 145177.     CrossRef
  • A practical approach to the clinical challenges in initiation of basal insulin therapy in people with type 2 diabetes
    Thomas Forst, Pratik Choudhary, Doron Schneider, Bruno Linetzky, Paolo Pozzilli
    Diabetes/Metabolism Research and Reviews.2021;[Epub]     CrossRef
  • Bewusstseinsstörung, Tachypnoe und Tachykardie bei einem 71-jährigen Patienten mit Diabetes mellitus Typ 2
    S. Großmann, U. Hoffmann, C. Girlich
    Der Internist.2021; 62(6): 672.     CrossRef
  • Good Glycemic Outcomes Following Bariatric Surgery Among Patients With Type 2 Diabetes, Obesity, and Low-Titer GAD Antibodies
    Ruveena Kaur, David Kim, Richard Cutfield, Michael Booth, Lindsay Plank, Rinki Murphy
    Diabetes Care.2021; 44(2): 607.     CrossRef
  • Slowly evolving, immune-mediated diabetes in 14-year-old patient: a case report
    M. R. Ragimov, D. D. Omelchuk, L. I. Ibragimova, O. S. Derevyanko, T. V. Nikonova
    Diabetes mellitus.2021; 24(1): 70.     CrossRef
  • Combination of vitamin D and dipeptidyl peptidase-4 inhibitors (VIDPP-4i) as an immunomodulation therapy for autoimmune diabetes
    Marcelo Maia Pinheiro, Felipe Moura Maia Pinheiro, Susana Nogueira Diniz, Andrea Fabbri, Marco Infante
    International Immunopharmacology.2021; 95: 107518.     CrossRef
  • Current view of diagnosis and treatment of latent autoimmune diabetes in adults
    Jana Urbanová, Ludmila Brunerová, Jana Malinovská, Barbora Pelechová, Ludmila Koberová, Jan Brož
    Vnitřní lékařství.2021; 67(2): 97.     CrossRef
  • Alpha‐amylase as molecular target for treatment of diabetes mellitus: A comprehensive review
    Navjot Kaur, Vanktesh Kumar, Surendra Kumar Nayak, Pankaj Wadhwa, Paranjit Kaur, Sanjeev Kumar Sahu
    Chemical Biology & Drug Design.2021; 98(4): 539.     CrossRef
  • CLINICAL AND IMMUNOLOGICAL ASPECTS OF VERIFICATION OF LATENT AUTOIMMUNE DIABETES IN ADULTS AT EARLY STAGES OF DISEASE MANIFESTATION
    Tetiana М. Tykhonova, Igor V. Belozоrov, Nadiya Ye. Barabash, Larysa O. Martymianova
    Wiadomości Lekarskie.2021; 74(7): 1707.     CrossRef
  • Bacillus Calmette-Guerin 's beneficial impact on glucose metabolism: Evidence for broad based applications
    Gabriella F. Shpilsky, Hiroyuki Takahashi, Anna Aristarkhova, Michele Weil, Nathan Ng, Kacie J. Nelson, Amanda Lee, Hui Zheng, Willem M. Kühtreiber, Denise L. Faustman
    iScience.2021; 24(10): 103150.     CrossRef
  • Multicentre analysis of hyperglycaemic hyperosmolar state and diabetic ketoacidosis in type 1 and type 2 diabetes
    S. R. Tittel, K. M. Sondern, M. Weyer, T. Poeplau, B. M. Sauer, M. Schebek, K.-H. Ludwig, F. Hammer, E. Fröhlich-Reiterer, R. W. Holl
    Acta Diabetologica.2020; 57(10): 1245.     CrossRef
  • Pancreas Pathology of Latent Autoimmune Diabetes in Adults (LADA) in Patients and in a LADA Rat Model Compared With Type 1 Diabetes
    Anne Jörns, Dirk Wedekind, Joachim Jähne, Sigurd Lenzen
    Diabetes.2020; 69(4): 624.     CrossRef
  • Past, present and future of latent autoimmune diabetes in adults
    Bingwen Liu, Yufei Xiang, Zhenqi Liu, Zhiguang Zhou
    Diabetes/Metabolism Research and Reviews.2020;[Epub]     CrossRef
  • Adult-onset autoimmune diabetes in 2020: An update
    Ernesto Maddaloni, Chiara Moretti, Carmen Mignogna, Raffaella Buzzetti
    Maturitas.2020; 137: 37.     CrossRef
  • Altered peripheral nerve structure and function in latent autoimmune diabetes in adults
    Tushar Issar, Aimy Yan, Natalie C. G. Kwai, Ann M. Poynten, Adeniyi A. Borire, Ria Arnold, Arun V. Krishnan
    Diabetes/Metabolism Research and Reviews.2020;[Epub]     CrossRef
  • Low rate of latent autoimmune diabetes in adults (LADA) in patients followed for type 2 diabetes: A single center’s experience in Turkey
    Abbas Ali Tam, Didem Ozdemir, Nagihan Bestepe, Fatma Dilek Dellal, Muhammet Cuneyt Bilginer, Sevgul Faki, Cemile Bicer, Reyhan Ersoy, Bekir Cakir
    Archives of Endocrinology and Metabolism.2020;[Epub]     CrossRef
  • Distinguishing between type 1 and type 2 diabetes
    Alexandra E Butler, David Misselbrook
    BMJ.2020; : m2998.     CrossRef
  • Exogenous Insulin Injection-Induced Stiff-Person Syndrome in a Patient With Latent Autoimmune Diabetes: A Case Report and Literature Review
    Yi-Yin Lee, Cheng-Wei Lin, I-Wen Chen
    Frontiers in Endocrinology.2020;[Epub]     CrossRef
  • Investigating optimal β‐cell‐preserving treatment in latent autoimmune diabetes in adults: Results from a 21‐month randomized trial
    Ingrid K. Hals, Hanne Fiskvik Fleiner, Nina Reimers, Marianne C. Astor, Karin Filipsson, Zuheng Ma, Valdemar Grill, Anneli Björklund
    Diabetes, Obesity and Metabolism.2019; 21(10): 2219.     CrossRef
  • Immunological and clinical characteristics of latent autoimmune diabetes in the elderly
    Silvina Yohena, Alberto Penas‐Steinhardt, Clara Muller, Natalia I. Faccinetti, Gloria E. Cerrone, Silvia Lovecchio, Edgardo Ridner, Silvina Valdez, Gustavo Frechtel
    Diabetes/Metabolism Research and Reviews.2019;[Epub]     CrossRef
  • Autoimmunity in latent autoimmune diabetes in adults
    Alessandro P. Delitala
    AIMS Medical Science.2019; 6(2): 132.     CrossRef
Close layer
Original Article
Clinical Study
Characteristics of Korean Patients with Primary Adrenal Insufficiency: A Registry-Based Nationwide Survey in Korea
A Ram Hong, Ohk-Hyun Ryu, Seong Yeon Kim, Sang Wan Kim
Endocrinol Metab. 2017;32(4):466-474.   Published online December 14, 2017
DOI: https://doi.org/10.3803/EnM.2017.32.4.466
  • 5,824 View
  • 64 Download
  • 14 Web of Science
  • 12 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   
Background

Primary adrenal insufficiency (PAI) is a rare, potentially life-threatening condition. There are few Korean studies on PAI, and most have had small sample sizes. We aimed to examine the etiology, clinical characteristics, treatment, and mortality of PAI in Korean patients.

Methods

A nationwide, multicenter, registry-based survey was conducted to identify adults diagnosed with or treated for PAI at 30 secondary or tertiary care institutions in Korea between 2000 and 2014.

Results

A total of 269 patients with PAI were identified. The prevalence of PAI was 4.17 per million. The estimated incidence was 0.45 per million per year. The mean age at diagnosis was 49.0 years, and PAI was more prevalent in men. Adrenal tuberculosis was the most common cause of PAI in patients diagnosed before 2000; for those diagnosed thereafter, adrenal metastasis and tuberculosis were comparable leading causes. The etiology of PAI was not identified in 34.9% of cases. Of the patients receiving glucocorticoid replacement therapy, prednisolone was more frequently administered than hydrocortisone (69.4% vs. 26.5%, respectively), and only 27.1% of all patients received fludrocortisone. We observed an increased prevalence of metabolic disease and osteoporosis during the follow-up period (median, 60.2 months). The observed overall mortality and disease-specific mortality rates were 11.9% and 3.1%, respectively.

Conclusion

The prevalence of PAI is significantly lower in Koreans than in reports from Western countries. The high frequency undetermined etiology in patients with PAI suggests the need to reveal accurate etiology of PAI in Korea.

Citations

Citations to this article as recorded by  
  • Genetic and phenotypic spectrum of non-21-hydroxylase-deficiency primary adrenal insufficiency in childhood: data from 111 Chinese patients
    Ying Duan, Wanqi Zheng, Yu Xia, Huiwen Zhang, Lili Liang, Ruifang Wang, Yi Yang, Kaichuang Zhang, Deyun Lu, Yuning Sun, Lianshu Han, Yongguo Yu, Xuefan Gu, Yu Sun, Bing Xiao, Wenjuan Qiu
    Journal of Medical Genetics.2024; 61(1): 27.     CrossRef
  • Approach to the Patient: Diagnosis of Primary Adrenal Insufficiency in Adults
    Marianne Øksnes, Eystein S Husebye
    The Journal of Clinical Endocrinology & Metabolism.2023; 109(1): 269.     CrossRef
  • Epidemiology and Causes of Primary Adrenal Insufficiency in Children: A Population-Based Study
    Joonatan Borchers, Eero Pukkala, Outi Mäkitie, Saila Laakso
    The Journal of Clinical Endocrinology & Metabolism.2023; 108(11): 2879.     CrossRef
  • Primary Adrenal Insufficiency in Acute Progressive Systemic Inflammation Accompanied by Latent Tuberculosis: A Case Report
    Kasumi Nishikawa, Mizuki Nitta, Shoma Tanaka, Chiaki Sano, Ryuichi Ohta
    Cureus.2023;[Epub]     CrossRef
  • What factors have impact on glucocorticoid replacement in adrenal insufficiency: a real-life study
    S. Puglisi, A. Rossini, I. Tabaro, S. Cannavò, F. Ferrau’, M. Ragonese, G. Borretta, M. Pellegrino, F. Dughera, A. Parisi, A. Latina, A. Pia, M. Terzolo, G. Reimondo
    Journal of Endocrinological Investigation.2021; 44(4): 865.     CrossRef
  • Adrenal insufficiency
    Eystein S Husebye, Simon H Pearce, Nils P Krone, Olle Kämpe
    The Lancet.2021; 397(10274): 613.     CrossRef
  • Towards the tailoring of glucocorticoid replacement in adrenal insufficiency: the Italian Society of Endocrinology Expert Opinion
    A. M. Isidori, G. Arnaldi, M. Boscaro, A. Falorni, C. Giordano, R. Giordano, R. Pivonello, C. Pozza, E. Sbardella, C. Simeoli, C. Scaroni, A. Lenzi
    Journal of Endocrinological Investigation.2020; 43(5): 683.     CrossRef
  • Novel ABCD1 Gene Mutation in a Korean Patient with X-Linked Adrenoleukodystrophy Presenting with Addison's Disease
    Yun Kyung Cho, Seo-Young Lee, Sang-Wook Kim
    Endocrinology and Metabolism.2020; 35(1): 188.     CrossRef
  • Encountering COVID-19 as Endocrinologists
    Eun-Jung Rhee, Jung Hee Kim, Sun Joon Moon, Won-Young Lee
    Endocrinology and Metabolism.2020; 35(2): 197.     CrossRef
  • Prednisolone is associated with a worse bone mineral density in primary adrenal insufficiency
    Kathrin R Frey, Tina Kienitz, Julia Schulz, Manfred Ventz, Kathrin Zopf, Marcus Quinkler
    Endocrine Connections.2018; 7(6): 811.     CrossRef
  • The potential role for infections in the pathogenesis of autoimmune Addison’s disease
    A Hellesen, E Bratland
    Clinical and Experimental Immunology.2018; 195(1): 52.     CrossRef
  • Evaluation and Treatment of Adrenal Dysfunction in the Primary Care Environment
    Shannon Cole
    Nursing Clinics of North America.2018; 53(3): 385.     CrossRef
Close layer
Review Articles
Thyroid
Recent Advances in Autoimmune Thyroid Diseases
Won Sang Yoo, Hyun Kyung Chung
Endocrinol Metab. 2016;31(3):379-385.   Published online August 26, 2016
DOI: https://doi.org/10.3803/EnM.2016.31.3.379
  • 6,046 View
  • 126 Download
  • 31 Web of Science
  • 33 Crossref
AbstractAbstract PDFPubReader   

Autoimmune thyroid disease (AITD) includes hyperthyroid Graves disease, hypothyroid autoimmune thyroiditis, and subtle subclinical thyroid dysfunctions. AITD is caused by interactions between genetic and environmental predisposing factors and results in autoimmune deterioration. Data on polymorphisms in the AITD susceptibility genes, related environmental factors, and dysregulation of autoimmune processes have accumulated over time. Over the last decade, there has been progress in the clinical field of AITD with respect to the available diagnostic and therapeutic methods as well as clinical consensus. The updated clinical guidelines allow practitioners to identify the most reasonable and current approaches for proper management. In this review, we focus on recent advances in understanding the genetic and environmental pathogenic mechanisms underlying AITD and introduce the updated set of clinical guidelines for AITD management. We also discuss other aspects of the disease such as management of subclinical thyroid dysfunction, use of levothyroxine plus levotriiodothyronine in the treatment of autoimmune hypothyroidism, risk assessment of long-standing antithyroid drug therapy in recurrent Graves' hyperthyroidism, and future research needs.

Citations

Citations to this article as recorded by  
  • A Mendelian randomization study of the effect of serum 25-hydroxyvitamin D levels on autoimmune thyroid disease
    Yunfeng Yu, Xinyu Yang, Jingyi Wu, Xueli Shangguan, Siyang Bai, Rong Yu
    Frontiers in Immunology.2024;[Epub]     CrossRef
  • Therapeutic Potential of CRISPR/Cas in Hashimoto's Thyroiditis: A Comprehensive Review
    Apoorva Upreti, Sayali Mukherjee
    Current Gene Therapy.2024; 24(3): 179.     CrossRef
  • Salenio: clinical study design
    Domenico Parmeggiani, Paola Bassi, Maddalena Claudia Donnarumma, Chiara Colonnese, Vincenzo Ieluzzi, Laura Pacca, Chiara Agresti, Massimo Agresti
    Endocrinology&Metabolism International Journal.2023; 11(1): 1.     CrossRef
  • Medical Applications of Molecular Biotechnologies in the Context of Hashimoto’s Thyroiditis
    Maria Trovato, Andrea Valenti
    Diagnostics.2023; 13(12): 2114.     CrossRef
  • IMMUNOHISTOCHEMICAL CHARACTERISTICS OF THYROID GLAND CHANGES IN PATIENTS WITH AUTOIMMUNE THYROIDITIS
    F. G. Sadikhov
    World of Medicine and Biology.2023; 19(84): 139.     CrossRef
  • The C55A Single Nucleotide Polymorphism in CTLA-4 Gene, a New Possible Biomarker in Thyroid Autoimmune Pathology Such as Hashimoto’s Thyroiditis
    Alin-Dan Chiorean, Mihaela Laura Vica, Ștefana Bâlici, Gheorghe Zsolt Nicula, Nicoleta Răcătăianu, Mădălina Adriana Bordea, Laura-Mihaela Simon, Horea Vladi Matei
    Diagnostics.2023; 13(15): 2517.     CrossRef
  • USING LASER PHOTODYNAMIC THERAPY IN THE TREATMENT OF AUTOIMMUNE THYROIDITIS
    F. G. Sadikhov
    World of Medicine and Biology.2023; 19(85): 166.     CrossRef
  • Autoimmune thyroiditis in different age groups and subjects of reproductive age in Adzhariya population
    N. G. Tchelidze, S. Z. Glonti, D. Sh. Baratashvili, N. O. Kedelidze, J. Yu. Ungiadze, I. I. Nakashidze
    Obstetrics, Gynecology and Reproduction.2022; 16(1): 8.     CrossRef
  • Alterations and Mechanism of Gut Microbiota in Graves’ Disease and Hashimoto’s Thyroiditis
    Hong Zhao, Lijie Yuan, Dongli Zhu, Banghao Sun, Juan Du, Jingyuan Wang
    Polish Journal of Microbiology.2022; 71(2): 173.     CrossRef
  • The association of six autoimmune bullous diseases with thyroid disorders: a population‐based study
    K. Kridin, F. Hübner, R. Linder, E. Schmidt
    Journal of the European Academy of Dermatology and Venereology.2022; 36(10): 1826.     CrossRef
  • Investigation of comorbid autoimmune diseases in women with autoimmune bullous diseases: An interplay of autoimmunity and practical implications
    Meropi Karakioulaki, Dedee F. Murrell, Aikaterini Kyriakou, Aikaterini Patsatsi
    International Journal of Women’s Dermatology.2022; 8(3): e053.     CrossRef
  • Best Achievements in Translational and Basic Thyroidology in 2020
    Sun Wook Cho, Young Joo Park
    Endocrinology and Metabolism.2021; 36(1): 36.     CrossRef
  • Incidence and Clinical Implications of Autoimmune Thyroiditis in the Development of Acne in Young Patients
    Laura Endres, Delia Mirela Tit, Simona Bungau, Nicoleta Anamaria Pascalau, Laura Maghiar Țodan, Erika Bimbo-Szuhai, Gabriela Mariana Iancu, Nicoleta Negrut
    Diagnostics.2021; 11(5): 794.     CrossRef
  • Attaining Euthyroidism - Seal the Loopholes
    Payel Biswas, Subhankar Chatterjee
    International Journal of Thyroidology.2021; 14(1): 69.     CrossRef
  • Cardiac Autonomic Modulation and Anti-Thyroid Peroxidase (TPO) Antibodies in Subclinical Hypothyroidism – Does Any Correlation Exist?
    Manisha Mavai, Dr Bharti Bhandari , Anish Singhal, Sandeep K Mathur
    Cureus.2021;[Epub]     CrossRef
  • Sensibilidade ao glúten e tireoidite de Hashimoto: uma interação viável
    Larissa Barros Pinto Franco, Fernanda Neves Pinto, Claudia Teresa Bento, Carla Viana Dendasck
    Revista Científica Multidisciplinar Núcleo do Conhecimento.2021; : 110.     CrossRef
  • Chronic urticaria and thyroid pathology
    Sandra Nora Gonzalez-Diaz, Mario Sanchez-Borges, Diana Maria Rangel-Gonzalez, Rosa Ivett Guzman-Avilan, Jose Ignacio Canseco-Villarreal, Alfredo Arias-Cruz
    World Allergy Organization Journal.2020; 13(3): 100101.     CrossRef
  • Genome-Wide Analysis Identifies Two Susceptibility Loci for Positive Thyroid Peroxidase and Thyroglobulin Antibodies
    Antonela Matana, Thibaud Boutin, Vesela Torlak, Dubravka Brdar, Ivana Gunjača, Ivana Kolčić, Vesna Boraska Perica, Ante Punda, Ozren Polašek, Maja Barbalić, Caroline Hayward, Tatijana Zemunik
    The Journal of Clinical Endocrinology & Metabolism.2020; 105(3): 944.     CrossRef
  • Iodine and bromine in fish consumed by indigenous peoples of the Russian Arctic
    Nikita Sobolev, Andrey Aksenov, Tatiana Sorokina, Valery Chashchin, Dag G. Ellingsen, Evert Nieboer, Yulia Varakina, Elena Plakhina, Alexandra Onuchina, Magny Skinlo Thomassen, Yngvar Thomassen
    Scientific Reports.2020;[Epub]     CrossRef
  • Significance of arsenic and lead in Hashimoto's thyroiditis demonstrated on thyroid tissue, blood, and urine samples
    Aleksandar Stojsavljević, Branislav Rovčanin, Jovana Jagodić, Danijela Drašković Radojković, Ivan Paunović, Marija Gavrović-Jankulović, Dragan Manojlović
    Environmental Research.2020; 186: 109538.     CrossRef
  • Prognostic Value of Caspase-1, Interleukin-1β, Tumor Necrosis Factor-α and Interleukin-18 Activity in Patients with Gastroesophageal Reflux Disease and Autoimmune Thyroiditis
    T. M. Pasiieshvili, O. M. Kovaloyva, L. M. Pasiieshvili , N. M. Zhelezniakova
    Ukraïnsʹkij žurnal medicini, bìologìï ta sportu.2020; 5(4): 202.     CrossRef
  • A historical excursus of diagnostic methods for Hashimoto thyroiditis and Graves' disease
    Maria Trovato
    Gazzetta Medica Italiana Archivio per le Scienze Mediche.2020;[Epub]     CrossRef
  • The value of preoperative antithyroidperoxidase antibody as a novel predictor of recurrence in papillary thyroid carcinoma
    Eyun Song, Hye‐Seon Oh, Min Ji Jeon, Ki Wook Chung, Suck Joon Hong, Jin Sook Ryu, Jung Hwan Baek, Jeong Hyun Lee, Won Gu Kim, Won Bae Kim, Young Kee Shong, Tae Yong Kim
    International Journal of Cancer.2019; 144(6): 1414.     CrossRef
  • Hydatid cyst of the thyroid gland with tracheal fistula: A case report and review of the literature
    Tiemin Jiang, Qiang Guo, Bo Ran, Ruiqing Zhang, Tuerganaili Aji, Yingmei Shao
    Experimental and Therapeutic Medicine.2019;[Epub]     CrossRef
  • Thyroid diseases and skin autoimmunity
    Enke Baldini, Teresa Odorisio, Chiara Tuccilli, Severino Persechino, Salvatore Sorrenti, Antonio Catania, Daniele Pironi, Giovanni Carbotta, Laura Giacomelli, Stefano Arcieri, Massimo Vergine, Massimo Monti, Salvatore Ulisse
    Reviews in Endocrine and Metabolic Disorders.2018; 19(4): 311.     CrossRef
  • Does severe vitamin D deficiency impact obstetric outcomes in pregnant women with thyroid autoimmunity?
    Halenur Bozdag, Esra Akdeniz
    The Journal of Maternal-Fetal & Neonatal Medicine.2018; : 1.     CrossRef
  • Constitutive Changes in Circulating Follicular Helper T Cells and Their Subsets in Patients with Graves’ Disease
    Yan Liu, Xinwang Yuan, Xiaofang Li, Dawei Cui, Jue Xie
    Journal of Immunology Research.2018; 2018: 1.     CrossRef
  • Comorbidity of autoimmune thyroid disorders and psychiatric disorders during the postpartum period: a Danish nationwide register-based cohort study
    V. Bergink, V. J. M. Pop, P. R. Nielsen, E. Agerbo, T. Munk-Olsen, X. Liu
    Psychological Medicine.2018; 48(8): 1291.     CrossRef
  • Spontaneous conversion from Graves’ disease to Hashimoto’s thyroiditis: a case report
    Muharrem Bayrak, Kenan Çadırcı, Emine Kartal Baykan, Ünsal Aydın, Ayşe Çarlıoğlu
    Ortadoğu Tıp Dergisi.2018; 10(1): 81.     CrossRef
  • Role of T Follicular Helper (Tfh) Cells Plasticity in Autoimmune Thyroiditis among Hepatitis C Virus Infection
    Helal F Hetta
    Gastroenterology & Hepatology: Open Access.2017;[Epub]     CrossRef
  • Variants of Interleukin-22 Gene Confer Predisposition to Autoimmune Thyroid Disease
    Rong-hua Song, Qian Li, Wen Wang, Qiu-ming Yao, Xiao-qing Shao, Jin-an Zhang
    International Journal of Endocrinology.2017; 2017: 1.     CrossRef
  • Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia
    Clodoveo Ferri, Michele Colaci, Poupak Fallahi, Silvia Martina Ferrari, Alessandro Antonelli, Dilia Giuggioli
    Frontiers in Endocrinology.2017;[Epub]     CrossRef
  • Articles inEndocrinology and Metabolismin 2016
    Won-Young Lee
    Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef
Close layer
Thyroid
Clinical Relevance of Environmental Factors in the Pathogenesis of Autoimmune Thyroid Disease
Wilmar M. Wiersinga
Endocrinol Metab. 2016;31(2):213-222.   Published online May 13, 2016
DOI: https://doi.org/10.3803/EnM.2016.31.2.213
  • 9,373 View
  • 213 Download
  • 89 Web of Science
  • 93 Crossref
AbstractAbstract PDFPubReader   

Genetic factors contribute for about 70% to 80% and environmental factors for about 20% to 30% to the pathogenesis of autoimmune thyroid disease (AITD). Relatives of AITD patients carry a risk to contract AITD themselves. The 5-year risk can be quantified by the so-called Thyroid Events Amsterdam-score, based on serum thyroid-stimulating hormone, thyroid peroxidase (TPO)-antibodies and family history. Subjects at risk may ask what they can do to prevent development of AITD. This review summarizes what is known about modulation of exposure to environmental factors in terms of AITD prevention. To stop smoking decreases the risk on Graves disease but increases the risk on Hashimoto disease. Moderate alcohol intake provides some protection against both Graves and Hashimoto disease. Low selenium intake is associated with a higher prevalence of thyroid autoimmunity, but evidence that selenium supplementation may lower TPO antibodies and prevent subclinical hypothyroidism remains inconclusive. Low serum vitamin D levels are associated with a higher prevalence of TPO antibodies, but intervention studies with extra vitamin D have not been done yet. Stress may provoke Graves hyperthyroidism but not Hashimoto thyroiditis. Estrogen use have been linked to a lower prevalence of Graves disease. The postpartum period is associated with an increased risk of AITD. Taking together, preventive interventions to diminish the risk of AITD are few, not always feasible, and probably of limited efficacy.

Citations

Citations to this article as recorded by  
  • Trends in Prevalence of Thyroid Dysfunction and its Associations With Mortality Among US Participants, 1988-2012
    Xiaowen Zhang, Yong Wang, Hongwei Wang, Xinlin Zhang
    The Journal of Clinical Endocrinology & Metabolism.2024; 109(2): e657.     CrossRef
  • The role of medical and organizational measures in improving the quality of early detection and clinical examination of autoimmune thyroiditis among the population of the Republic of Belarus
    L. I. Danilova, V. A. Rozhko, I. V. Veyalkin, S. N. Nikanovich, T. M. Sharshakova
    Health and Ecology Issues.2024; 20(4): 129.     CrossRef
  • Hyperthyroidism
    Layal Chaker, David S Cooper, John P Walsh, Robin P Peeters
    The Lancet.2024; 403(10428): 768.     CrossRef
  • A Review of Thyroid Dysfunction Due to COVID-19
    Alireza Arefzadeh
    Mini-Reviews in Medicinal Chemistry.2024; 24(3): 265.     CrossRef
  • Alteration in kynurenine pathway metabolites in young women with autoimmune thyroiditis
    Anna Krupa, Agnieszka Łebkowska, Marcin Kondraciuk, Karol Adam Kaminski, Irina Kowalska
    Scientific Reports.2024;[Epub]     CrossRef
  • Association of autoimmune thyroid disease with type 1 diabetes mellitus and its ultrasonic diagnosis and management
    Jin Wang, Ke Wan, Xin Chang, Rui-Feng Mao
    World Journal of Diabetes.2024; 15(3): 348.     CrossRef
  • Hashimoto’s thyroiditis and coexisting disorders in correlation with HLA status—an overview
    Peter Mikosch, Adrian Aistleitner, Markus Oehrlein, Eva Trifina-Mikosch
    Wiener Medizinische Wochenschrift.2023; 173(1-2): 41.     CrossRef
  • The management and metabolic characterization: hyperthyroidism and hypothyroidism
    Yangyang Wang, YanPing Sun, Bingyou Yang, Qiuhong Wang, Haixue Kuang
    Neuropeptides.2023; 97: 102308.     CrossRef
  • Zn and Se abrogate heavy metal mixture induced ovarian and thyroid oxido-inflammatory effects mediated by activation of NRF2-HMOX-1 in female albino rats
    Boma F. Eddie-Amadi, Anthonet N. Ezejiofor, Chinna N. Orish, Orish E. Orisakwe
    Current Research in Toxicology.2023; 4: 100098.     CrossRef
  • Genetically predicted selenium concentrations and thyroid function: A two‐sample Mendelian randomization study
    Hui‐Jun Huang, Shan‐Shan Wang, Ming‐Min Jin, Bin‐Wei Cheng, Yu Liu, Xiao‐Chen Liu, Qiu‐Yan Yu, Xin‐Jun Yang
    Clinical Endocrinology.2023; 98(6): 813.     CrossRef
  • Identification of Smoking-Associated Transcriptome Aberration in Blood with Machine Learning Methods
    FeiMing Huang, QingLan Ma, JingXin Ren, JiaRui Li, Fen Wang, Tao Huang, Yu-Dong Cai, Bilal Alatas
    BioMed Research International.2023; 2023: 1.     CrossRef
  • COVID-induced thyroid autoimmunity
    Alessandro Brancatella, Nicola Viola, Ferruccio Santini, Francesco Latrofa
    Best Practice & Research Clinical Endocrinology & Metabolism.2023; 37(2): 101742.     CrossRef
  • Associations between vitamin D levels and dietary patterns in patients with Hashimoto’s thyroiditis
    Dean Kaličanin, Maja Cvek, Ana Barić, Veselin Škrabić, Ante Punda, Vesna Boraska Perica
    Frontiers in Nutrition.2023;[Epub]     CrossRef
  • COMPARATIVE MORPHOLOGY OF THE THYROID GLAND
    L. O. Sviatotska
    Bulletin of Problems Biology and Medicine.2023; 1(2): 386.     CrossRef
  • Evaluation and epigenetic impact of B12, vitamin D, folic acid and anemia in Hashimoto's thyroiditis: a clinical and molecular docking study
    Elif Sibel ASLAN, Savaş GÜR
    Journal of Health Sciences and Medicine.2023; 6(4): 705.     CrossRef
  • Interactions between Polygenetic Variants and Lifestyle Factors in Hypothyroidism: A Hospital-Based Cohort Study
    Da Sol Kim, Sunmin Park
    Nutrients.2023; 15(17): 3850.     CrossRef
  • Do Dietary Supplements Affect Inflammation, Oxidative Stress, and Antioxidant Status in Adults with Hypothyroidism or Hashimoto’s Disease?—A Systematic Review of Controlled Trials
    Katarzyna Kubiak, Maria Karolina Szmidt, Joanna Kaluza, Agnieszka Zylka, Ewa Sicinska
    Antioxidants.2023; 12(10): 1798.     CrossRef
  • Identification and Preliminary Clinical Validation of Key Extracellular Proteins as the Potential Biomarkers in Hashimoto’s Thyroiditis by Comprehensive Analysis
    Zihan Xi, Tinglin Yang, Tao Huang, Jun Zhou, Peng Yang
    Biomedicines.2023; 11(12): 3127.     CrossRef
  • An examination of retinal findings with optical coherence tomography in hypothyroidism patients with vitamin D deficiency: A comparative study
    Samet Sayılan, Dila Kırağı, Mehmet Tayfun Arslan
    Journal of Clinical Medicine of Kazakhstan.2023; 20(6): 36.     CrossRef
  • The role of IL-4 −590 (C>T) Gene as diagnostic biomarker of Hashimoto thyroiditis disease patients in AL-Najaf provenance /Iraq
    Sarah Hasan Kadhum AL-Huchaimi, Mahdi Hussain AL-Ammar, Sabah N. AL-Fatlawi
    Al-Kufa University Journal for Biology.2023; 15(3): 14.     CrossRef
  • Early life stress in women with autoimmune thyroid disorders
    Alessia Corso, Hermann Engel, Fabienne Müller, Serena Fiacco, Laura Mernone, Elena Gardini, Ulrike Ehlert, Susanne Fischer
    Scientific Reports.2023;[Epub]     CrossRef
  • Protective Effects of Selenium and Zinc Against Nickel Chloride–Induced Hormonal Changes and Oxidative Damage in Thyroid of Pregnant Rats
    Imane Salah, Ounassa Adjroud, Awatef Elwej
    Biological Trace Element Research.2022; 200(5): 2183.     CrossRef
  • Effects of animal protein intake during pregnancy on autoimmune thyroiditis in pregnant women with mild iodine deficiency
    Zhengyuan Wang, Jiaying Shen, Qi Song, Xueying Cui, Zehuan Shi, Jin Su, Jiajie Zang
    Journal of Human Nutrition and Dietetics.2022; 35(3): 542.     CrossRef
  • Positive antithyroid antibody predicts severity of neuromyelitis optica spectrum disorder in children
    Liang Huo, Hua Wang, Yujun Yuan, Jian Gao, Xueyan Liu
    Multiple Sclerosis and Related Disorders.2022; 57: 103425.     CrossRef
  • Seasonality of month of birth in patients with autoimmune endocrine diseases: A systematic review
    Ana M. Ramos-Leví, Gloria Collado, Monica Marazuela
    Endocrinología, Diabetes y Nutrición.2022; 69(10): 779.     CrossRef
  • Are ethnic differences, urinary iodine status, lead and cadmium exposure associated with thyroid autoimmunity and hypothyroid status? A cross-sectional study
    Yi Chen, Qian Xiang, Ningjian Wang, Wen Zhang, Chunfang Zhu, Yuying Wang, Heng Wan, Jing Cheng, Kun Zhang, Yan Cai, Yingli Lu
    BMJ Open.2022; 12(2): e056909.     CrossRef
  • The Association of Thyroid Nodules With Blood Trace Elements Identified in a Cross-Section Study
    Huixian Zeng, Yuanyuan Hu, Yaosheng Luo, Yanshi Ye, Cheng Song, Genfeng Yu, Zhi Chen, Siyang Liu, Yongqian Liang, Lingling Liu, Heng Wan, Jie Shen
    Frontiers in Nutrition.2022;[Epub]     CrossRef
  • Nutritional Management of Thyroiditis of Hashimoto
    Yana Danailova, Tsvetelina Velikova, Georgi Nikolaev, Zorka Mitova, Alexander Shinkov, Hristo Gagov, Rossitza Konakchieva
    International Journal of Molecular Sciences.2022; 23(9): 5144.     CrossRef
  • Association Between Vitamin D Deficiency and Autoimmune Thyroid Disorder: A Systematic Review
    Sabah A Khozam, Abdulhadi M Sumaili, Mohammed A Alflan, Rawan As'ad Salameh Shawabkeh
    Cureus.2022;[Epub]     CrossRef
  • Metabolic Characteristics of Hashimoto’s Thyroiditis Patients and the Role of Microelements and Diet in the Disease Management—An Overview
    Aniceta A. Mikulska, Marta Karaźniewicz-Łada, Dorota Filipowicz, Marek Ruchała, Franciszek K. Główka
    International Journal of Molecular Sciences.2022; 23(12): 6580.     CrossRef
  • Predictors of autoimmune thyroid disease
    Carol Cardona Attard, W. C. Candy Sze, Sandro Vella
    Baylor University Medical Center Proceedings.2022; 35(5): 608.     CrossRef
  • Selenium Status and Supplementation Effects in Pregnancy—A Study on Mother–Child Pairs from a Single-Center Cohort
    Dorota Filipowicz, Ewelina Szczepanek-Parulska, Małgorzata Kłobus, Krzysztof Szymanowski, Thilo Samson Chillon, Sabrina Asaad, Qian Sun, Aniceta A. Mikulska-Sauermann, Marta Karaźniewicz-Łada, Franciszek K. Główka, Dominika Wietrzyk, Lutz Schomburg, Marek
    Nutrients.2022; 14(15): 3082.     CrossRef
  • Inflammasome activation as a link between obesity and thyroid disorders: Implications for an integrated clinical management
    Rosario Le Moli, Veronica Vella, Dario Tumino, Tommaso Piticchio, Adriano Naselli, Antonino Belfiore, Francesco Frasca
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Seasonality of month of birth in patients with autoimmune endocrine diseases: A systematic review
    Ana M. Ramos-Leví, Gloria Collado, Monica Marazuela
    Endocrinología, Diabetes y Nutrición (English ed.).2022; 69(10): 779.     CrossRef
  • Impact of iodine intake on the pathogenesis of autoimmune thyroid disease in children and adults
    Iyshwarya Bhaskar Kalarani, Ramakrishnan Veerabathiran
    Annals of Pediatric Endocrinology & Metabolism.2022; 27(4): 256.     CrossRef
  • Morphological features of thyroid benign focal neoplasms in Graves’ disease
    Yu.V. Buldygina, A.V. Zelinskaya, L.Yu. Zurnadzhy, Yu.M. Tarashchenko, S.L. Shlyakhtych, M.D. Tronko
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2022; 18(4): 213.     CrossRef
  • Onset of Marine-Lenhart syndrome and Graves’ ophthalmopathy in a female patient treated with alemtuzumab for multiple sclerosis
    Rosario Le Moli, Marco Russo, Pasqualino Malandrino, Veronica Vella, Antonino Belfiore, Francesco Frasca
    Hormones.2021; 20(1): 161.     CrossRef
  • Limited Genetic Overlap Between Overt Hashimoto’s Thyroiditis and Graves’ Disease in Twins: A Population-based Study
    Jakob Skov, Jan Calissendorff, Daniel Eriksson, Patrik Magnusson, Olle Kämpe, Sophie Bensing, Ralf Kuja-Halkola
    The Journal of Clinical Endocrinology & Metabolism.2021; 106(4): e1101.     CrossRef
  • DNA Methylation Patterns in the HLA-DPB1 and PDCD1LG2 Gene Regions in Patients with Autoimmune Thyroiditis from Different Water Iodine Areas
    Siyuan Wan, Lixiang Liu, Bingxuan Ren, Mengying Qu, Huaiyong Wu, Wen Jiang, Xiaoming Wang, Hongmei Shen
    Thyroid.2021; 31(11): 1741.     CrossRef
  • Персоналізація лікування хвороби Грейвса на підставі клініко- імунологічних характеристик перебігу захворювання
    Yu.V. Buldygina, S.L. Shlyakhtych, H.M. Terekhova, T.V. Fed’ko, V.M. Klochkova, L.S. Strafun, Z.H. Lysova, I.I. Savos’ko
    Endokrynologia.2021; 26(4): 409.     CrossRef
  • Parity and Incidence of Thyroid Autoimmunity: A Population-Based Tehran Thyroid Study
    Miralireza Takyar, Maryam Rahmani, Atieh Amouzegar, Elham Madreseh, Maryam Tohidi, Ladan Mehran, Fereidoun Azizi
    Thyroid.2020; 30(8): 1186.     CrossRef
  • Immunomodulatory effect of vitamin D and its potential role in the prevention and treatment of thyroid autoimmunity: a narrative review
    D. Gallo, L. Mortara, M. B. Gariboldi, S. A. M. Cattaneo, S. Rosetti, L. Gentile, D. M. Noonan, P. Premoli, C. Cusini, M. L. Tanda, L. Bartalena, E. Piantanida
    Journal of Endocrinological Investigation.2020; 43(4): 413.     CrossRef
  • Hashimoto Thyreoiditis, therapeutische Optionen und extrathyreoidale Assoziationen – ein aktueller Überblick
    Eva Petnehazy, Wolfgang Buchinger
    Wiener Medizinische Wochenschrift.2020; 170(1-2): 26.     CrossRef
  • Pathophysiological Role and Therapeutic Implications of Vitamin D in Autoimmunity: Focus on Chronic Autoimmune Diseases
    Mattia Bellan, Laura Andreoli, Chiara Mele, Pier Paolo Sainaghi, Cristina Rigamonti, Silvia Piantoni, Carla De Benedittis, Gianluca Aimaretti, Mario Pirisi, Paolo Marzullo
    Nutrients.2020; 12(3): 789.     CrossRef
  • Thyroxine-binding globulin, peripheral deiodinase activity, and thyroid autoantibody status in association of phthalates and phenolic compounds with thyroid hormones in adult population
    Sohyeon Choi, Min Joo Kim, Young Joo Park, Sunmi Kim, Kyungho Choi, Gi Jeong Cheon, Yoon Hee Cho, Hye Li Jeon, Jiyoung Yoo, Jeongim Park
    Environment International.2020; 140: 105783.     CrossRef
  • Immunomodulatory Effects of Vitamin D in Thyroid Diseases
    Chiara Mele, Marina Caputo, Alessandro Bisceglia, Maria Teresa Samà, Marco Zavattaro, Gianluca Aimaretti, Loredana Pagano, Flavia Prodam, Paolo Marzullo
    Nutrients.2020; 12(5): 1444.     CrossRef
  • Significance of arsenic and lead in Hashimoto's thyroiditis demonstrated on thyroid tissue, blood, and urine samples
    Aleksandar Stojsavljević, Branislav Rovčanin, Jovana Jagodić, Danijela Drašković Radojković, Ivan Paunović, Marija Gavrović-Jankulović, Dragan Manojlović
    Environmental Research.2020; 186: 109538.     CrossRef
  • Graves’ disease: Epidemiology, genetic and environmental risk factors and viruses
    Alessandro Antonelli, Silvia Martina Ferrari, Francesca Ragusa, Giusy Elia, Sabrina Rosaria Paparo, Ilaria Ruffilli, Armando Patrizio, Claudia Giusti, Debora Gonnella, Alfonso Cristaudo, Rudy Foddis, Yehuda Shoenfeld, Poupak Fallahi
    Best Practice & Research Clinical Endocrinology & Metabolism.2020; 34(1): 101387.     CrossRef
  • Vitamin D deficiency and thyroid autoantibody fluctuations in patients with Graves’ disease – A mere coincidence or a real relationship?
    Maria Teresa Płazińska, Agata Czarnywojtek, Nadia Sawicka-Gutaj, Małgorzata Zgorzalewicz-Stachowiak, Barbara Czarnocka, Paweł Gut, Maria Karlinska, Marta Fichna, Adam Stachowski, Marek Ruchała, Iwona Krela-Kaźmierczak, Leszek Królicki
    Advances in Medical Sciences.2020; 65(1): 39.     CrossRef
  • An eight-year-old girl with autoimmune polyglandular syndrome type3A that developed during the course of primary Epstein–Barr virus (EBV) infection: clinical implication of EBV in autoimmune thyroid disease
    Shizuka Kirino, Hisae Nakatani, Aoi Honma, Asami Shinbo, Keiko Onda, Mari Okada, Masako Imai, Natsuko Suzuki, Akihiro Oshiba, Masayuki Nagasawa
    Immunological Medicine.2020; 43(1): 57.     CrossRef
  • Exploring the role of copper and selenium in the maintenance of normal thyroid function among healthy Koreans
    Min Joo Kim, Soo Chin Kim, Soie Chung, Serim Kim, Ji Won Yoon, Young Joo Park
    Journal of Trace Elements in Medicine and Biology.2020; 61: 126558.     CrossRef
  • A comparison of serum zinc levels in melasma and non-melasma patients: a preliminary study of thyroid dysfunction
    Indina Sastrini Sekarnesia, Irma Bernadette S. Sitohang, Triana Agustin, Wismandari Wisnu, Aida S. D. Hoemardani
    Acta Dermatovenerologica Alpina Pannonica et Adriatica.2020;[Epub]     CrossRef
  • Hashimoto's thyroiditis: An update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation
    Massimo Ralli, Diletta Angeletti, Marco Fiore, Vittorio D'Aguanno, Alessandro Lambiase, Marco Artico, Marco de Vincentiis, Antonio Greco
    Autoimmunity Reviews.2020; 19(10): 102649.     CrossRef
  • Vitamin D and Autoimmune Thyroid Disease—Cause, Consequence, or a Vicious Cycle?
    Inês Henriques Vieira, Dírcea Rodrigues, Isabel Paiva
    Nutrients.2020; 12(9): 2791.     CrossRef
  • New Insights into Mechanisms of Endocrine-Disrupting Chemicals in Thyroid Diseases: The Epigenetic Way
    Letizia Pitto, Francesca Gorini, Fabrizio Bianchi, Elena Guzzolino
    International Journal of Environmental Research and Public Health.2020; 17(21): 7787.     CrossRef
  • Genotype association of IP6K3 gene with Hashimoto’s thyroiditis in Algerian population (Aures region)
    Warda Kherrour, Dean Kalicanin, Luka Brčić, Leila Hambaba, Mouloud Yahia, Souheyla Benbia, Vesna Boraska Perica
    Egyptian Journal of Medical Human Genetics.2020;[Epub]     CrossRef
  • TOTAL ANTIOXIDANT ACTIVITY AND MANGANESE SUPEROXIDE DISMUTASE IN COMORBIDITY OF GASTROESOPHAGEAL REFLUX DISEASE AND AUTOIMMUNE THYROIDITIS IN STUDENT POPULATION
    Tamara M. Pasiieshvili, Natalia M. Zhelezniakova, Lyudmila M. Pasiyeshvili, Olga M. Kovalyova
    Wiadomości Lekarskie.2020; 73(12): 2644.     CrossRef
  • Vitamin B12 and Vitamin D Levels in Patients with Autoimmune Hypothyroidism and Their Correlation with Anti-Thyroid Peroxidase Antibodies
    Hanife Şerife Aktaş
    Medical Principles and Practice.2020; 29(4): 364.     CrossRef
  • Increased Risk of Thyroid Dysfunction Among Patients With Rheumatoid Arthritis
    Qian Li, Bin Wang, Kaida Mu, Jing Zhang, Yanping Yang, Wei Yao, Jie Zhu, Jin-an Zhang
    Frontiers in Endocrinology.2019;[Epub]     CrossRef
  • Association between thyroglobulin polymorphisms and autoimmune thyroid disease: a systematic review and meta-analysis of case–control studies
    Ming-Liang Zhang, Dong-ming Zhang, Cai-E. Wang, Xiao-Long Chen, Fang-Zhou Liu, Jian-Xue Yang
    Genes & Immunity.2019; 20(6): 484.     CrossRef
  • Changes in glucose‐lipid metabolism, insulin resistance, and inflammatory factors in patients with autoimmune thyroid disease
    Yi Lei, Jun Yang, Hua Li, Haihua Zhong, Qin Wan
    Journal of Clinical Laboratory Analysis.2019;[Epub]     CrossRef
  • Evaluation of Qualitative Dietary Protocol (Diet4Hashi) Application in Dietary Counseling in Hashimoto Thyroiditis: Study Protocol of a Randomized Controlled Trial
    Natalia Wojtas, Lidia Wadolowska, Elżbieta Bandurska-Stankiewicz
    International Journal of Environmental Research and Public Health.2019; 16(23): 4841.     CrossRef
  • Sjögren’s Syndrome and Autoimmune Thyroid Disease: Two Sides of the Same Coin
    Juan-Manuel Anaya, Paula Restrepo-Jiménez, Yhojan Rodríguez, Mónica Rodríguez-Jiménez, Yeny Acosta-Ampudia, Diana M. Monsalve, Yovana Pacheco, Carolina Ramírez-Santana, Nicolás Molano-González, Rubén D. Mantilla
    Clinical Reviews in Allergy & Immunology.2019; 56(3): 362.     CrossRef
  • Disease Presentation and Remission Rate in Graves Disease Treated With Antithyroid Drugs: is Gender Really A Factor?
    Talia Diker-Cohen, Hadar Duskin-Bitan, Ilan Shimon, Dania Hirsch, Amit Akirov, Gloria Tsvetov, Eyal Robenshtok
    Endocrine Practice.2019; 25(1): 43.     CrossRef
  • IRAK2 and TLR10 confer risk of Hashimoto’s disease: a genetic association study based on the Han Chinese population
    Miao Li, Wei Han, Li Zhu, Jue Jiang, Wei Qu, Lei Zhang, Liang Jia, Qi Zhou
    Journal of Human Genetics.2019; 64(7): 617.     CrossRef
  • Environmental exposure to pesticides and risk of thyroid diseases
    Mar Requena, Antonia López-Villén, Antonio F. Hernández, Tesifón Parrón, Ángela Navarro, Raquel Alarcón
    Toxicology Letters.2019; 315: 55.     CrossRef
  • Determining the Level of Knowledge about Graves’ Disease: Single-Center Results
    Hande Peynirci, Çiğdem Uzuntepe Aksu, Akif Doğan, Canan Ersoy
    Ankara Medical Journal.2019;[Epub]     CrossRef
  • Association between lifestyle and thyroid dysfunction: a cross-sectional epidemiologic study in the She ethnic minority group of Fujian Province in China
    Yanling Huang, Liangchun Cai, Yuanyuan Zheng, Jinxing Pan, Liantao Li, Liyao Zong, Wei Lin, Jixing Liang, Huibin Huang, Junping Wen, Gang Chen
    BMC Endocrine Disorders.2019;[Epub]     CrossRef
  • Vitamin D Receptor Gene Polymorphisms and Autoimmune Thyroiditis: Are They Associated with Disease Occurrence and Its Features?
    Adam Maciejewski, Michał J. Kowalczyk, Waldemar Herman, Adam Czyżyk, Marta Kowalska, Ryszard Żaba, Katarzyna Łącka
    BioMed Research International.2019; 2019: 1.     CrossRef
  • Diagnosis of Graves’ disease – laboratory tests and possible difficulties in interpretation
    Agata Maria Kalicka
    Diagnostyka Laboratoryjna.2019; 55(2): 121.     CrossRef
  • The influence of single-nucleotide polymorphisms of interleukin-1β -511 and +3954 on the susceptibility to Hashimoto’s thyroiditis in Egyptian women: immune-endocrine interactions
    Nearmeen M. Rashad, Manar H. Soliman, Mayada M. Mousa, Azza H. Abd El-Fatah
    The Egyptian Journal of Internal Medicine.2019; 31(1): 14.     CrossRef
  • Global epidemiology of hyperthyroidism and hypothyroidism
    Peter N. Taylor, Diana Albrecht, Anna Scholz, Gala Gutierrez-Buey, John H. Lazarus, Colin M. Dayan, Onyebuchi E. Okosieme
    Nature Reviews Endocrinology.2018; 14(5): 301.     CrossRef
  • Selenoproteins in human body: focus on thyroid pathophysiology
    Ana Valea, Carmen Emanuela Georgescu
    Hormones.2018; 17(2): 183.     CrossRef
  • Epidemiology of hyperthyroidism in Iran: a systematic review and meta-analysis
    Sayed Mahmoud Sajjadi-Jazi, Farshad Sharifi, Mehdi Varmaghani, Hamidreza Aghaei Meybodi, Farshad Farzadfar, Bagher Larijani
    Journal of Diabetes & Metabolic Disorders.2018; 17(2): 345.     CrossRef
  • The effect of vitamin D supplementation on thyroid autoantibody levels in the treatment of autoimmune thyroiditis: a systematic review and a meta-analysis
    Su Wang, Yaping Wu, Zhihua Zuo, Yijing Zhao, Kun Wang
    Endocrine.2018; 59(3): 499.     CrossRef
  • Thyroid disorders in alemtuzumab-treated multiple sclerosis patients: a Belgian consensus on diagnosis and management
    Brigitte Decallonne, Emmanuel Bartholomé, Valérie Delvaux, Miguel D’haeseleer, Souraya El Sankari, Pierrette Seeldrayers, Bart Van Wijmeersch, Chantal Daumerie
    Acta Neurologica Belgica.2018; 118(2): 153.     CrossRef
  • Synergistic interactions of Angiotensin Converting Enzyme (ACE) gene and Apolipoprotein E (APOE) gene polymorphisms with T1DM susceptibility in south India
    Padma-Malini Ravi, Rathika Chinniah, Ramgopal Sivanadham, Murali Vijayan, Dharmarajan Pannerselvam, S. Pushkala, Balakrishnan Karuppiah
    Meta Gene.2018; 18: 39.     CrossRef
  • The effect of obesity and dietary habits on oxidative stress in Hashimoto’s thyroiditis
    Maria Giannakou, Katerina Saltiki, Emily Mantzou, Eleni Loukari, Georgios Philippou, Konstantinos Terzidis, Charalampos Stavrianos, Miltiades Kyprianou, Theodora Psaltopoulou, Kalliopi Karatzi, Maria Alevizaki
    Endocrine Connections.2018; 7(9): 990.     CrossRef
  • Interaction of HLA-DRB1* alleles and CTLA4 (+ 49 AG) gene polymorphism in Autoimmune Thyroid Disease
    Sivanadham Ramgopal, Chinniah Rathika, Malini Ravi Padma, Vijayan Murali, Kannan Arun, Mohamed Nainar Kamaludeen, Karuppiah Balakrishnan
    Gene.2018; 642: 430.     CrossRef
  • New insights into the etiopathogenesis of Hashimoto's Thyroiditis: The role of genetics and epigenetics
    Massimo Ralli, Armando De Virgilio, Marco Artico, Lucia Longo, Marco de Vincentiis, Antonio Greco
    Autoimmunity Reviews.2018; 17(10): 1065.     CrossRef
  • Comorbidity of autoimmune thyroid disorders and psychiatric disorders during the postpartum period: a Danish nationwide register-based cohort study
    V. Bergink, V. J. M. Pop, P. R. Nielsen, E. Agerbo, T. Munk-Olsen, X. Liu
    Psychological Medicine.2018; 48(8): 1291.     CrossRef
  • Spontaneous conversion from Graves’ disease to Hashimoto’s thyroiditis: a case report
    Muharrem Bayrak, Kenan Çadırcı, Emine Kartal Baykan, Ünsal Aydın, Ayşe Çarlıoğlu
    Ortadoğu Tıp Dergisi.2018; 10(1): 81.     CrossRef
  • Association of established hypothyroidism-associated genetic variants with Hashimoto’s thyroiditis
    A. Barić, L. Brčić, S. Gračan, V. Torlak Lovrić, I. Gunjača, M. Šimunac, M. Brekalo, M. Boban, O. Polašek, M. Barbalić, T. Zemunik, A. Punda, V. Boraska Perica
    Journal of Endocrinological Investigation.2017; 40(10): 1061.     CrossRef
  • Immune Response of Laying Hens Exposed to 30 ppm Ammonia for 25 Weeks
    H. Chen, F.F. Yan, J.Y. Hu, Yanan Wu, C.M. Tucker, A.R. Green, H.W. Cheng
    International Journal of Poultry Science.2017; 16(4): 139.     CrossRef
  • Dietary Factors Associated with Plasma Thyroid Peroxidase and Thyroglobulin Antibodies
    Antonela Matana, Vesela Torlak, Dubravka Brdar, Marijana Popović, Bernarda Lozić, Maja Barbalić, Vesna Boraska Perica, Ante Punda, Ozren Polašek, Caroline Hayward, Tatijana Zemunik
    Nutrients.2017; 9(11): 1186.     CrossRef
  • Articles inEndocrinology and Metabolismin 2016
    Won-Young Lee
    Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef
  • Does vitamin D play a role in autoimmune endocrine disorders? A proof of concept
    Barbara Altieri, Giovanna Muscogiuri, Luigi Barrea, Chantal Mathieu, Carla V. Vallone, Luca Mascitelli, Giorgia Bizzaro, Vincenzo M. Altieri, Giacomo Tirabassi, Giancarlo Balercia, Silvia Savastano, Nicola Bizzaro, Cristina L. Ronchi, Annamaria Colao, Alf
    Reviews in Endocrine and Metabolic Disorders.2017; 18(3): 335.     CrossRef
  • A case‐control study of the association between ulcerative colitis and hyperthyroidism in an Asian population
    Ming‐Chieh Tsai, Herng‐Ching Lin, Cha‐Ze Lee
    Clinical Endocrinology.2017; 86(6): 825.     CrossRef
  • Hashimoto's thyroiditis: relative recurrence risk ratio and implications for screening of first‐degree relatives
    Nikita Bothra, Nalini Shah, Manjunath Goroshi, Swati Jadhav, Sheetal Padalkar, Hemangini Thakkar, Gurudayal Singh Toteja, Vyankatesh Shivane, Anurag Lila, Tushar Bandgar
    Clinical Endocrinology.2017; 87(2): 201.     CrossRef
  • Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature
    Dilia Giuggioli, M. Colaci, G. Cassone, P. Fallahi, F. Lumetti, A. Spinella, F. Campomori, A. Manfredi, C. U. Manzini, A. Antonelli, C. Ferri
    Clinical Rheumatology.2017; 36(3): 583.     CrossRef
  • Are Perinatal Events Risk Factors for Childhood Thyroid Autoimmunity?
    Berglind Jonsdottir, Markus Lundgren, Sara Wallengren, Åke Lernmark, Ida Jönsson, Helena Elding Larsson
    European Thyroid Journal.2017; 6(6): 298.     CrossRef
  • Variants of Interleukin-22 Gene Confer Predisposition to Autoimmune Thyroid Disease
    Rong-hua Song, Qian Li, Wen Wang, Qiu-ming Yao, Xiao-qing Shao, Jin-an Zhang
    International Journal of Endocrinology.2017; 2017: 1.     CrossRef
  • Environmental Issues in Thyroid Diseases
    Silvia Martina Ferrari, Poupak Fallahi, Alessandro Antonelli, Salvatore Benvenga
    Frontiers in Endocrinology.2017;[Epub]     CrossRef
Close layer
Case Reports
Obesity and Metabolism
Recurrent Insulin Autoimmune Syndrome Caused by α-Lipoic Acid in Type 2 Diabetes
Sang Mook Bae, Myoung Nam Bae, Eun Young Kim, Il Kyu Kim, Min Woo Seo, Jin Kyeong Shin, Sung Rae Cho, Gui Hwa Jeong
Endocrinol Metab. 2013;28(4):326-330.   Published online December 12, 2013
DOI: https://doi.org/10.3803/EnM.2013.28.4.326
  • 3,858 View
  • 50 Download
  • 17 Crossref
AbstractAbstract PDFPubReader   

Insulin autoimmune syndrome (IAS) is characterized by spontaneous hypoglycemia caused by insulin autoantibodies in the absence of exogenous insulin administration. Some drugs containing sulfhydryl compounds are known to initiate the onset of IAS. A 67-year-old female who had diabetes for 5 years visited the outpatient clinic at our institution due to diabetic peripheral polyneuropathy. She was prescribed α-lipoic acid (ALA), which contains two sulfur atoms. Two weeks later, she complained of recurrent hypoglycemic symptoms. We detected a high level of insulin and high titers of insulin autoantibodies. Her human leukocyte antigen (HLA) genotype included the DRB1*0406 allele, which indicates a high level of susceptibility to IAS. She was treated with prednisolone. After this episode, she experienced two more hypoglycemic events after taking ALA for diabetic neuropathy in other hospitals. As ALA can be used to treat diabetic peripheral polyneuropathy, physician discretion is advised based on the possibility of IAS due to ALA in diabetic patients.

Citations

Citations to this article as recorded by  
  • Long-term follow-up after discharge witnesses a slow decline of insulin autoantibodies in patients with insulin autoimmune syndrome complicated with Grave’s disease: a report of two cases
    Lili Zhao, Jinzhi He, Shandong Ye, Chao Chen, Jie Zhu, Chunchun Xiao, Tingni Wu, Zhicheng Liu
    BMC Endocrine Disorders.2023;[Epub]     CrossRef
  • Postprandial hyperinsulinemic hypoglycemia
    A. A. Akmedova, F. O. Ushanova
    FOCUS. Endocrinology.2023; 4(3): 74.     CrossRef
  • Effects of alpha lipoic acid on metabolic syndrome: A comprehensive review
    Nahid Najafi, Soghra Mehri, Mahboobeh Ghasemzadeh Rahbardar, Hossein Hosseinzadeh
    Phytotherapy Research.2022; 36(6): 2300.     CrossRef
  • Alpha-Lipoic Acid and Glucose Metabolism: A Comprehensive Update on Biochemical and Therapeutic Features
    Umberto Capece, Simona Moffa, Ilaria Improta, Gianfranco Di Giuseppe, Enrico Celestino Nista, Chiara M. A. Cefalo, Francesca Cinti, Alfredo Pontecorvi, Antonio Gasbarrini, Andrea Giaccari, Teresa Mezza
    Nutrients.2022; 15(1): 18.     CrossRef
  • Analysis of the clinical characteristics of insulin autoimmune syndrome induced by alpha‐lipoic acid
    Zuojun Li, Yanhong Su, Dan Yi, Cuifang Wu, Weijin Fang, Chunjiang Wang
    Journal of Clinical Pharmacy and Therapeutics.2021; 46(5): 1295.     CrossRef
  • Scientific opinion on the relationship between intake of alpha‐lipoic acid (thioctic acid) and the risk of insulin autoimmune syndrome
    Dominique Turck, Jacqueline Castenmiller, Stefaan de Henauw, Karen Ildico Hirsch‐Ernst, John Kearney, Helle Katrine Knutsen, Inge Mangelsdorf, Harry J McArdle, Androniki Naska, Carmen Pelaez, Kristina Pentieva, Alfonso Siani, Frank Thies, Sophia Tsabouri,
    EFSA Journal.2021;[Epub]     CrossRef
  • Management of Insulin Autoimmune Hypoglycaemia: Single‐centre experience from Western India with systematic review of world literature
    Muniraj Patel, Ravikumar Shah, Swati Ramteke‐Jadhav, Virendra Patil, Shivendra Kumar Patel, Anurag Lila, Nalini Shah, Tushar Bandgar
    Clinical Endocrinology.2020; 92(5): 409.     CrossRef
  • Glucose Changes in a Patient With Insulin Autoimmune Syndrome Demonstrated by Continuous Glucose Monitoring
    Shi-Dou Lin, Shang-Ren Hsu
    AACE Clinical Case Reports.2019; 5(1): e35.     CrossRef
  • Insulin Autoimmune Syndrome in a 25-Year-Old, Previously Healthy Kuwaiti Man
    Einas Alrashidi, Thamer Alessa
    Case Reports in Endocrinology.2019; 2019: 1.     CrossRef
  • Insulin autoimmune syndrome in an Argentine woman taking α-lipoic acid: A case report and review of the literature
    Valentina Izzo, Carla Greco, Diana Corradini, Marco Infante, Maria Teresa Staltari, Maria Romano, Alfonso Bellia, Davide Lauro, Luigi Uccioli
    SAGE Open Medical Case Reports.2018; 6: 2050313X1881960.     CrossRef
  • Assessment and Management of Anti-Insulin Autoantibodies in Varying Presentations of Insulin Autoimmune Syndrome
    David Church, Luís Cardoso, Richard G Kay, Claire L Williams, Bernard Freudenthal, Catriona Clarke, Julie Harris, Myuri Moorthy, Efthmia Karra, Fiona M Gribble, Frank Reimann, Keith Burling, Alistair J K Williams, Alia Munir, T Hugh Jones, Dagmar Führer,
    The Journal of Clinical Endocrinology & Metabolism.2018; 103(10): 3845.     CrossRef
  • Current Status of Health Foods Including Their Interactions with Drugs and Adverse Events
    Yoshiro Saito
    YAKUGAKU ZASSHI.2018; 138(12): 1511.     CrossRef
  • Autoimmune hypoglycaemia caused by alpha-lipoic acid: a rare condition in Caucasian patients
    A Veltroni, G Zambon, S Cingarlini, M V Davì
    Endocrinology, Diabetes & Metabolism Case Reports.2018;[Epub]     CrossRef
  • GLP‑1R agonists ameliorate peripheral nerve dysfunction and inflammation via p38 MAPK/NF‑κB signaling pathways in streptozotocin‑induced diabetic rats
    Jingjing Ma, Min Shi, Xiangcheng Zhang, Xiaoning Liu, Juan Chen, Ridong Zhang, Xingzhou Wang, Hong Zhang
    International Journal of Molecular Medicine.2018;[Epub]     CrossRef
  • Insulin autoimmune syndrome associated with alpha-lipoic acid in a young woman with no concomitant disease
    Sang Bae Lee, Min Young Lee, Ji Hong You, Seong Han Kim, Ji Sun Nam
    Yeungnam University Journal of Medicine.2017; 34(1): 115.     CrossRef
  • The insulin autoimmune syndrome (IAS) as a cause of hypoglycaemia: an update on the pathophysiology, biochemical investigations and diagnosis
    Adel A.A. Ismail
    Clinical Chemistry and Laboratory Medicine (CCLM).2016; 54(11): 1715.     CrossRef
  • Brief Review of Articles in 'Endocrinology and Metabolism' in 2013
    Won-Young Lee
    Endocrinology and Metabolism.2014; 29(3): 251.     CrossRef
Close layer
Polyglandular Autoimmune Syndrome Type III with Primary Hypoparathyroidism
Sang Jin Kim, Sang-Yoon Kim, Han-Byul Kim, Hyukwon Chang, Ho-Chan Cho
Endocrinol Metab. 2013;28(3):236-240.   Published online September 13, 2013
DOI: https://doi.org/10.3803/EnM.2013.28.3.236
  • 4,087 View
  • 34 Download
  • 5 Crossref
AbstractAbstract PDFPubReader   

Polyglandular autoimmune syndrome is defined as multiple endocrine gland insufficiencies accompanied by autoimmune diseases of the endocrine and nonendocrine system. After Schmidt introduced a case of nontuberculosis adrenal gland dysfunction with thyroiditis in 1926, Neufeld defined polyglandular autoimmune syndrome by I, II, and III subtypes in 1980 by their presentation of occurrence age, heredity methods, relationship with human leukocyte antigen, and accompanying diseases. We report a case of a 32-year-old female with polyglandular autoimmune syndrome III accompanied by type 1 diabetes mellitus that was treated with insulin (36 units per day) for 11 years. She had insulin deficiency and Hashimoto thyroiditis as an autoimmune disorder. In addition, she had several features similar to Albright's hereditary osteodystrophy including short stature, truncal obesity, round face, short neck, low intelligence (full IQ 84), and decreased memory. Although Albright's hereditary osteodystrophy is morphological evidence of pseudohypoparathyroidism or pseudopseudohypoparathyroidism, she had primary hypoparathyroidism on laboratory results. Here, we report a case of polyglandular autoimmune syndrome III with type 1 diabetes mellitus, autoimmune thyroiditis, and primary hypoparathyroidism, accompanied by clinical features similar to Albright's hereditary osteodystrophy.

Citations

Citations to this article as recorded by  
  • Autoimmune polyglandular syndrome type III associated with antineutrophil cytoplasmic autoantibody-mediated crescentic glomerulonephritis
    Shiyuan Tian, Baofeng Xu, Ziwei Liu, Rui Liu
    Medicine.2020; 99(7): e19179.     CrossRef
  • Hypoparathyroidism: Genetics and Diagnosis
    Michael Mannstadt, Luisella Cianferotti, Rachel I Gafni, Francesca Giusti, Elizabeth Helen Kemp, Christian A Koch, Kelly L Roszko, Liam Yao, Gordon H Guyatt, Rajesh V Thakker, Weibo Xia, Maria-Luisa Brandi
    Journal of Bone and Mineral Research.2020; 37(12): 2615.     CrossRef
  • A rare case of polyglandular autoimmune syndrome type IIIc with primary antibody failure
    Adina Elena Stanciu, Florentina Sava, Gergely Toldi
    Gynecological Endocrinology.2018; 34(4): 283.     CrossRef
  • Autoimmune Polyendocrine Syndrome Type IIIC and Ankylosing Spondylitis; a Case Report
    Ali Javinani, Hamid Reza Aghaei Meybodi, Ahmad Reza Jamshidi, Farhad Gharibdoost, Hoda Kavosi
    Rheumatology Research.2016;[Epub]     CrossRef
  • Brief Review of Articles in 'Endocrinology and Metabolism' in 2013
    Won-Young Lee
    Endocrinology and Metabolism.2014; 29(3): 251.     CrossRef
Close layer
Thyroid
Steroid Responsive Xanthomatous Hypophysitis Associated with Autoimmune Thyroiditis: A Case Report
Ji Young Joung, Hyemin Jeong, Yoon Young Cho, Kyoungmin Huh, Yeon-Lim Suh, Kwang-Won Kim, Ji Cheol Bae
Endocrinol Metab. 2013;28(1):65-69.   Published online March 25, 2013
DOI: https://doi.org/10.3803/EnM.2013.28.1.65
  • 3,539 View
  • 30 Download
  • 16 Crossref
AbstractAbstract PDFPubReader   

We report the case of a 36-year-old woman who presented with headache, fever, and amenorrhea. Laboratory analysis revealed hypopituitarism and autoimmune thyroiditis, while a cerebrospinal fluid study suggested concurrent aseptic meningitis. A magnetic resonance image (MRI) scan revealed a 1.0×0.9 cm cystic mass enlarging the sella turcica. Surgical resection via an endoscopic transsphenoidal route was performed. The histological finding of the excised tissue revealed foamy histiocytes with vacuolated cytoplasm, supporting the diagnosis of xanthomatous hypophysitis. Although a residual soft lesion was observed on the MRI image postoperatively, the patient's headache and fever improved. Ten months after surgery, the patient complained of visual impairment and headache, and the residual mass had enlarged into the suprasellar area. High dose (500 mg intravenous) methylprednisolone was administered for 3 days. During the methylprednisolone pulse therapy, the patient's visual acuity and headache improved. A follow-up MRI taken after methylprednisolone therapy showed a marked mass reduction. Our case supports an autoimmune pathophysiology for xanthomatous hypophysitis and suggests that high dose glucocorticoid therapy as a treatment option.

Citations

Citations to this article as recorded by  
  • Xanthomatous hypophysitis causing hypogonadotropic hypogonadism resulting in delayed presentation of slipped capital femoral epiphysis
    Kirit Singh, Avinash Kumar Kanodia, Peter Ross, Antonia Torgersen, Jamie Maclean, Graham Leese, Kismet Hossain-Ibrahim
    British Journal of Neurosurgery.2022; 36(2): 286.     CrossRef
  • Full recovery from chronic headache and hypopituitarism caused by lymphocytic hypophysitis: A case report
    Mao-Guang Yang, Han-Qing Cai, Si-Si Wang, Lin Liu, Chun-Mei Wang
    World Journal of Clinical Cases.2022; 10(3): 1041.     CrossRef
  • Xanthomatous Hypophysitis Secondary to a Ruptured Rathke’s Cleft Cyst: A Case Report
    Emre Gezer, Burak Çabuk, Büşra Yaprak Bayrak, Zeynep Cantürk, Berrin Çetinarslan, Alev Selek, Mehmet Sözen, Damla Köksalan, Savaş Ceylan
    Brain Tumor Research and Treatment.2022; 10(1): 48.     CrossRef
  • Successful immunomodulatory treatment for recurrent xanthogranulomatous hypophysitis in an adolescent: illustrative case
    Sarah DeCou, Pablo F. Recinos, Richard A. Prayson, Christopher Karakasis, Anzar Haider, Neha Patel
    Journal of Neurosurgery: Case Lessons.2022;[Epub]     CrossRef
  • Xanthogranulomatous hypophysitis: A rare presentation in a young female patient
    Mohammad Ali Yaghoubi, Samira Zabihyan, Amin Saeidinia, Masoumeh Gharib, Ramin Ghiyasi Moghaddam
    Clinical Case Reports.2022;[Epub]     CrossRef
  • Xanthomatous Hypophysitis Presenting in an Adolescent Girl: A Long-Term Follow-Up of a Rare Case and Review of the Literature
    Jeanne Sze Lyn Wong, Azraai Bahari Nasruddin, Nalini M. Selveindran, Kartikasalwah Abd Latif, Fauziah Kassim, Sukanya Banerjee Nair, Janet Y.H. Hong
    AACE Clinical Case Reports.2021; 7(3): 220.     CrossRef
  • Xanthomatous Hypophysitis: A Case Report and Comprehensive Literature Review
    Jianyu Zhu, Zhicheng Wang, Wenze Wang, Jinghua Fan, Yi Zhang, Xiaoxu Li, Jie Liu, Shenzhong Jiang, Kan Deng, Lian Duan, Yong Yao, Huijuan Zhu
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Recurring Primary Xanthomatous Hypophysitis Behaving Like Pituitary Adenoma: Additional Case and Literature Review
    Mansour Mathkour, Tyler Zeoli, Cassidy Werner, Tyler Scullen, Juanita Garces, Joseph Keen, Marcus Ware
    World Neurosurgery.2020; 138: 27.     CrossRef
  • Imaging findings in hypophysitis: a review
    Ferdinando Caranci, Giuseppe Leone, Andrea Ponsiglione, Massimo Muto, Fabio Tortora, Mario Muto, Sossio Cirillo, Luca Brunese, Alfonso Cerase
    La radiologia medica.2020; 125(3): 319.     CrossRef
  • Hypophysitis in the era of immune checkpoint inhibitors and immunoglobulin G4-related disease
    Leen Wehbeh, Sama Alreddawi, Roberto Salvatori
    Expert Review of Endocrinology & Metabolism.2019; 14(3): 167.     CrossRef
  • Xanthomatous Hypophysitis Is Associated with Ruptured Rathke’s Cleft Cyst
    Kai Duan, Sylvia L. Asa, Daniel Winer, Zadeh Gelareh, Fred Gentili, Ozgur Mete
    Endocrine Pathology.2017; 28(1): 83.     CrossRef
  • Xanthomatous Hypophysitis Presenting with Diabetes Insipidus Completely Cured Through Transsphenoidal Surgery: Case Report and Literature Review
    Wei Lin, Lu Gao, Xiaopeng Guo, Wenze Wang, Bing Xing
    World Neurosurgery.2017; 104: 1051.e7.     CrossRef
  • Review of xanthomatous lesions of the sella
    B.K. Kleinschmidt‐DeMasters, Kevin O. Lillehei, Todd C. Hankinson
    Brain Pathology.2017; 27(3): 377.     CrossRef
  • Xanthomatous hypophysitis
    Bishoy Hanna, Yan M. Li, Timothy Beutler, Parul Goyal, Walter A. Hall
    Journal of Clinical Neuroscience.2015; 22(7): 1091.     CrossRef
  • Clinical Characteristics, Management, and Outcome of 22 Cases of Primary Hypophysitis
    Sun Mi Park, Ji Cheol Bae, Ji Young Joung, Yoon Young Cho, Tae Hun Kim, Sang-Man Jin, Sunghwan Suh, Kyu Yeon Hur, Kwang-Won Kim
    Endocrinology and Metabolism.2014; 29(4): 470.     CrossRef
  • Brief Review of Articles in 'Endocrinology and Metabolism' in 2013
    Won-Young Lee
    Endocrinology and Metabolism.2014; 29(3): 251.     CrossRef
Close layer
Thyroid
Two Cases of Methimazole-Induced Insulin Autoimmune Syndrome in Graves' Disease
Eun Roh, Ye An Kim, Eu Jeong Ku, Jae Hyun Bae, Hye Mi Kim, Young Min Cho, Young Joo Park, Kyong Soo Park, Seong Yeon Kim, Soo Heon Kwak
Endocrinol Metab. 2013;28(1):55-60.   Published online March 25, 2013
DOI: https://doi.org/10.3803/EnM.2013.28.1.55
  • 6,489 View
  • 72 Download
  • 15 Crossref
AbstractAbstract PDFPubReader   

We report here the cases of two females with Graves' disease who developed insulin autoimmune syndrome after treatment with methimazole. The patients exhibited a sudden altered mental state after treatment with methimazole for approximately 4 weeks. Patients had hypoglycemia with serum glucose below 70 mg/dL, and laboratory findings showed both high levels of serum insulin and high titers of insulin autoantibodies. The two women had never been exposed to insulin or oral antidiabetic agents, and there was no evidence of insulinoma in imaging studies. After glucose loading, serum glucose, and total insulin levels increased abnormally. One of the patient was found to have HLA-DRB1*0406, which is known to be strongly associated with methimazole-induced insulin autoimmune syndrome. After discontinuation of methimazole, hypoglycemic events disappeared within 1 month. Insulin autoantibody titer and insulin levels decreased within 5 months and there was no further development of hypoglycemic events. We present these cases with a review of the relevant literature.

Citations

Citations to this article as recorded by  
  • Insulin Autoimmune Syndrome: A Systematic Review
    MingXu Lin, YuHua Chen, Jie Ning, Tatsuya Kin
    International Journal of Endocrinology.2023; 2023: 1.     CrossRef
  • Safety of Antithyroid Drugs in Avoiding Hyperglycemia or Hypoglycemia in Patients With Graves’ Disease and Type 2 Diabetes Mellitus: A Literature Review
    Yu-Shan Hsieh
    Cureus.2023;[Epub]     CrossRef
  • Case report: hypoglycemia secondary to methimazole-induced insulin autoimmune syndrome in young Taiwanese woman with Graves’ disease
    Hsuan-Yu Wu, I-Hua Chen, Mei-Yueh Lee
    Medicine.2022; 101(25): e29337.     CrossRef
  • Analysis of the clinical characteristics of insulin autoimmune syndrome induced by methimazole
    Linli Sun, Weijin Fang, Dan Yi, Wei Sun, Chunjiang Wang
    Journal of Clinical Pharmacy and Therapeutics.2021; 46(2): 470.     CrossRef
  • Preoperative plasmapheresis experience in Graves’ disease patients with anti-thyroid drug-induced hepatotoxicity
    Tugce Apaydın, Onur Elbasan, Dilek Gogas Yavuz
    Transfusion and Apheresis Science.2020; 59(5): 102826.     CrossRef
  • Glycemic variation in uncontrolled Graves’ disease patients with normal glucose metabolism: Assessment by continuous glucose monitoring
    Gu Gao, Feng-fei Li, Yun Hu, Reng-na Yan, Bing-li Liu, Xiao-mei Liu, Xiao-fei Su, Jian-hua Ma, Gang Hu
    Endocrine.2019; 64(2): 265.     CrossRef
  • Insulin autoimmune syndrome induced by exogenous insulin injection: a four-case series
    Yimin Shen, Xiaoxiao Song, Yuezhong Ren
    BMC Endocrine Disorders.2019;[Epub]     CrossRef
  • Assessment and Management of Anti-Insulin Autoantibodies in Varying Presentations of Insulin Autoimmune Syndrome
    David Church, Luís Cardoso, Richard G Kay, Claire L Williams, Bernard Freudenthal, Catriona Clarke, Julie Harris, Myuri Moorthy, Efthmia Karra, Fiona M Gribble, Frank Reimann, Keith Burling, Alistair J K Williams, Alia Munir, T Hugh Jones, Dagmar Führer,
    The Journal of Clinical Endocrinology & Metabolism.2018; 103(10): 3845.     CrossRef
  • MANAGEMENT OF ENDOCRINE DISEASE: Pathogenesis and management of hypoglycemia
    Nana Esi Kittah, Adrian Vella
    European Journal of Endocrinology.2017; 177(1): R37.     CrossRef
  • Insulin autoimmune syndrome during the administration of clopidogrel
    Eijiro Yamada, Shuichi Okada, Tsugumichi Saito, Aya Osaki, Atushi Ozawa, Masanobu Yamada
    Journal of Diabetes.2016; 8(4): 588.     CrossRef
  • Hyperinsulinemic hypoglycemia associated with insulin antibodies caused by exogenous insulin analog
    Chih-Ting Su, Yi-Chun Lin
    Endocrinology, Diabetes & Metabolism Case Reports.2016;[Epub]     CrossRef
  • Anti-tuberculosis Treatment-Induced Insulin Autoimmune Syndrome
    Jung Suk Han, Han Ju Moon, Jin Seo Kim, Hong Il Kim, Cheol Hyeon Kim, Min Joo Kim
    The Ewha Medical Journal.2016; 39(4): 122.     CrossRef
  • 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
    Douglas S. Ross, Henry B. Burch, David S. Cooper, M. Carol Greenlee, Peter Laurberg, Ana Luiza Maia, Scott A. Rivkees, Mary Samuels, Julie Ann Sosa, Marius N. Stan, Martin A. Walter
    Thyroid.2016; 26(10): 1343.     CrossRef
  • Insulin Autoimmune Syndrome in a Patient with Hashimoto's Thyroiditis
    In Wook Song, Eugene Han, Nan Hee Cho, Ho Chan Cho
    Journal of Korean Thyroid Association.2014; 7(2): 180.     CrossRef
  • Brief Review of Articles in 'Endocrinology and Metabolism' in 2013
    Won-Young Lee
    Endocrinology and Metabolism.2014; 29(3): 251.     CrossRef
Close layer
Review Article
Vitamin D: A D-Lightful Vitamin for Health.
Michael F Holick
Endocrinol Metab. 2012;27(4):255-267.   Published online December 20, 2012
DOI: https://doi.org/10.3803/EnM.2012.27.4.255
  • 2,185 View
  • 43 Download
  • 9 Crossref
AbstractAbstract PDF
Vitamin D is a sunshine vitamin that has been produced on this earth for more than 500 million years. Because foods contain so little vitamin D most humans have always depended on sun exposure for their vitamin D requirement. Vitamin D deficiency has been defined as a serum 25-hydroxyvitamin D concentration < 20 ng/mL (50 nmol/L); vitamin D insufficiency as a serum 25-hydroxyvitamin D of 21-29 ng/mL and vitamin D sufficiency as a serum 25-hydroxyvitamin D of 30-100 ng/mL whereas toxicity is usually not seen until blood levels are above 150 ng/mL. Vitamin D deficiency is a global health problem that increases risk for metabolic bone diseases in children and adults as well as many chronic illnesses including autoimmune diseases, type 2 diabetes, cardiovascular disease, infectious disease, and cancer. The major causes of vitamin D deficiency are lack of adequate sensible exposure to sunlight, inadequate dietary intake and obesity. The United States Endocrine Society recommended that to prevent vitamin D deficiency in those at risk, children 1 year and older require 600-1,000 international unit (IU) of vitamin D daily and adults require 1,500-2,000 IU of vitamin D daily. Obese patients require 2-3 times more vitamin D to both treat and prevent vitamin D deficiency.

Citations

Citations to this article as recorded by  
  • Higher intakes of dietary caffeine are associated with 25-hydroxyvitamin D deficiency
    Qiwei Chen, Hamed Kord-Varkaneh, Heitor O. Santos, Rafael Genario, Minyan Dang
    International Journal for Vitamin and Nutrition Research.2022; 92(2): 85.     CrossRef
  • WITHDRAWN: Higher intakes of dietary caffeine are associated with 25-hydroxyvitamin D deficiency: a study from the NHANES
    Fang Yang, Ning Wang
    Nutrition.2021; : 111380.     CrossRef
  • Association of metabolic syndrome and 25‐hydroxyvitamin D with cognitive impairment among elderly Koreans
    Eun Young Lee, Su Jin Lee, Kyoung Min Kim, Young Mi Yun, Bo Mi Song, Jong Eun Kim, Hyeon Chang Kim, Yumie Rhee, Yoosik Youm, Chang Oh Kim
    Geriatrics & Gerontology International.2017; 17(7): 1069.     CrossRef
  • Korean Society for Bone and Mineral Research Task Force Report: Perspectives on Intermittent High-dose Vitamin D Supplementation
    Han Seok Choi, Yong-Ki Min, Dong Won Byun, Myung Hoon Hahn, Kyoung Min Kim, Beom Jun Kim, Ki-Won Oh
    Journal of Bone Metabolism.2017; 24(3): 141.     CrossRef
  • Efficacy and safety of vitamin D3 B.O.N intramuscular injection in Korean adults with vitamin D deficiency
    Han Seok Choi, Yoon-Sok Chung, Yong Jun Choi, Da Hea Seo, Sung-Kil Lim
    Osteoporosis and Sarcopenia.2016; 2(4): 228.     CrossRef
  • Endocrine Risk Factors for Cognitive Impairment
    Jae Hoon Moon
    Endocrinology and Metabolism.2016; 31(2): 185.     CrossRef
  • The effect of thyroid stimulating hormone suppressive therapy on bone geometry in the hip area of patients with differentiated thyroid carcinoma
    Jae Hoon Moon, Kyong Yeun Jung, Kyoung Min Kim, Sung Hee Choi, Soo Lim, Young Joo Park, Do Joon Park, Hak Chul Jang
    Bone.2016; 83: 104.     CrossRef
  • Serum 25‐hydroxyvitamin D level and the risk of mild cognitive impairment and dementia: the Korean Longitudinal Study on Health and Aging (KLoSHA)
    J.H. Moon, S. Lim, J.W. Han, K.M. Kim, S.H. Choi, K.W. Kim, H.C. Jang
    Clinical Endocrinology.2015; 83(1): 36.     CrossRef
  • Vitamin D Status in Korea
    Han Seok Choi
    Endocrinology and Metabolism.2013; 28(1): 12.     CrossRef
Close layer
Case Reports
Autoimmune Thyroiditis during Antiviral Therapy with Peginterferon.
Jung Min Roh, Jeong Seon Yoo, Yoon Bum Lee, Hye Rim An, Hong Kyu Choi, Kyo Tae Jung, Jong Suk Park, Kwan Sik Lee, Kyung Rae Kim
J Korean Endocr Soc. 2010;25(1):68-71.   Published online March 1, 2010
DOI: https://doi.org/10.3803/jkes.2010.25.1.68
  • 1,626 View
  • 25 Download
AbstractAbstract PDF
Combination treatment with pegylated interferon and ribavirin has been established as a standard therapy for chronic hepatitis C. Although interferon therapy is relatively safe, an important side effect is the induction of autoantibodies and autoimmune disease, especially autoimmune thyroid disease. Interferon associated autoimmune thyroid disease can consist of autoimmune hypothyroidism, Graves' disease, and destructive thyroiditis. Thyroid disease may lead to dose reduction or discontinuation of therapy.
Close layer
A Case of Hashimoto's Thyroiditis Accompanied by Autoimmune Hepatitis Diagnosed with Liver Biopsy.
Young Jun Lee, Ji Yoon Sung, Sei Hyun Kim, Hyon Seung Yi, Yun Soo Kim, Sihoon Lee, Ie Byung Park
J Korean Endocr Soc. 2009;24(4):287-292.   Published online December 1, 2009
DOI: https://doi.org/10.3803/jkes.2009.24.4.287
  • 1,927 View
  • 23 Download
  • 2 Crossref
AbstractAbstract PDF
Autoimmune thyroid diseases, including Hashimoto's thyroiditis (HT), are common organ-specific autoimmune disorders that often occur in conjunction with other autoimmune diseases. Autoimmune hepatitis (AIH) is a relatively rare disease of unknown etiology. In this condition, progressive destruction of the liver parenchyma occurs. Without proper treatment with immunosuppressive agents, such as prednisone and azathioprine, this condition leads to cirrhosis and liver failure. Timely detection and appropriate treatment of the AIH is prerequisite for the long-term survival of affected patients. We report here a case of HT accompanied by AIH confirmed by liver biopsy. On the basis of this case report, we suggest that, a sustained elevation of aminotransferases refractory to thyroid dysfunction correction should result in a liver biopsy to differentiate AIH from other forms of liver dysfunction or secondary to thyroid disorders. Treatment should commence promptly.

Citations

Citations to this article as recorded by  
  • Autoimmune Hashimoto thyroiditis with concomitant autoimmune hepatitis
    Nevena Manevska, Natasa Stojkovska, Ljubica Tasheva, Marija Jovanovski-Srceva, Tanja Makazlieva, Sinisha Stojanoski
    Archives of Public Health.2022;[Epub]     CrossRef
  • A Case of Demyelinating Peripheral Neuropathy Associated with Hashimoto`s Thyroiditis
    Jung Hwan Park M.D., Sang Mo Hong M.D., Chang Bum Lee M.D., Yong Soo Park M.D., Dong Sun Kim M.D., Woong Hwan Choi M.D., You Hern Ahn M.D.
    Journal of the Korean Geriatrics Society.2011; 15(4): 234.     CrossRef
Close layer

Endocrinol Metab : Endocrinology and Metabolism